BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2:612-619. [PMID: 11429545 DOI: 10.1038/89759] [Cited by in Crossref: 904] [Cited by in F6Publishing: 867] [Article Influence: 43.0] [Reference Citation Analysis]
Number Citing Articles
1 Andersson P, Serhan CN, Petasis NA, Palmblad J. Interactions between lipoxin A4, the stable analogue 16-phenoxy-lipoxin A4 and leukotriene B4 in cytokine generation by human monocytes. Scand J Immunol 2004;60:249-56. [PMID: 15320881 DOI: 10.1111/j.0300-9475.2004.01469.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
2 Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Laniado Schwartzman M. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem. 2005;280:15267-15278. [PMID: 15708862 DOI: 10.1074/jbc.m410638200] [Cited by in Crossref: 209] [Cited by in F6Publishing: 121] [Article Influence: 12.3] [Reference Citation Analysis]
3 Vartak T, Godson C, Brennan E. Therapeutic potential of pro-resolving mediators in diabetic kidney disease. Adv Drug Deliv Rev 2021;178:113965. [PMID: 34508793 DOI: 10.1016/j.addr.2021.113965] [Reference Citation Analysis]
4 Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92-101. [PMID: 24899309 DOI: 10.1038/nature13479] [Cited by in Crossref: 1482] [Cited by in F6Publishing: 1393] [Article Influence: 185.3] [Reference Citation Analysis]
5 Prieto P, Cuenca J, Través PG, Fernández-velasco M, Martín-sanz P, Boscá L. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways. Cell Death Differ 2010;17:1179-88. [DOI: 10.1038/cdd.2009.220] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 5.6] [Reference Citation Analysis]
6 Louis NA, Hamilton KE, Colgan SP. Lipid mediator networks and leukocyte transmigration. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005;73:197-202. [DOI: 10.1016/j.plefa.2005.05.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
7 Dirou S, Voiriot G. [Anti-inflammatory drugs and community-acquired pneumonia]. Rev Mal Respir 2015;32:841-4. [PMID: 26372616 DOI: 10.1016/j.rmr.2015.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Howard NC, Khader SA. Immunometabolism during Mycobacterium tuberculosis Infection. Trends Microbiol 2020;28:832-50. [PMID: 32409147 DOI: 10.1016/j.tim.2020.04.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
9 Thurnher M. Small Drops Get Fat: Unexpected Fatty Acid in Cytoplasmic Lipid Droplets. Cell Chem Biol 2016;23:637-8. [PMID: 27341429 DOI: 10.1016/j.chembiol.2016.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Zheng DJ, Abou Taka M, Heit B. Role of Apoptotic Cell Clearance in Pneumonia and Inflammatory Lung Disease. Pathogens 2021;10:134. [PMID: 33572846 DOI: 10.3390/pathogens10020134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Kasikara C, Doran AC, Cai B, Tabas I. The role of non-resolving inflammation in atherosclerosis. J Clin Invest 2018;128:2713-23. [PMID: 30108191 DOI: 10.1172/JCI97950] [Cited by in Crossref: 92] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
12 Chee B, Park B, Fitzsimmons T, Coates AM, Bartold PM. Omega-3 fatty acids as an adjunct for periodontal therapy-a review. Clin Oral Investig 2016;20:879-94. [PMID: 26885664 DOI: 10.1007/s00784-016-1750-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
13 Reátegui E, Jalali F, Khankhel AH, Wong E, Cho H, Lee J, Serhan CN, Dalli J, Elliott H, Irimia D. Microscale arrays for the profiling of start and stop signals coordinating human-neutrophil swarming. Nat Biomed Eng 2017;1:0094. [PMID: 29057147 DOI: 10.1038/s41551-017-0094] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 9.6] [Reference Citation Analysis]
14 Jadapalli JK, Halade GV. Unified nexus of macrophages and maresins in cardiac reparative mechanisms. FASEB J 2018;32:5227-37. [PMID: 29750575 DOI: 10.1096/fj.201800254R] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Yin P, Wei Y, Wang X, Zhu M, Feng J. Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury. Front Neurol 2018;9:617. [PMID: 30131754 DOI: 10.3389/fneur.2018.00617] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
16 Baker PR, Lin Y, Schopfer FJ, Woodcock SR, Groeger AL, Batthyany C, Sweeney S, Long MH, Iles KE, Baker LM, Branchaud BP, Chen YE, Freeman BA. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J Biol Chem 2005;280:42464-75. [PMID: 16227625 DOI: 10.1074/jbc.M504212200] [Cited by in Crossref: 266] [Cited by in F6Publishing: 136] [Article Influence: 15.6] [Reference Citation Analysis]
17 Giannakis N, Sansbury BE, Patsalos A, Hays TT, Riley CO, Han X, Spite M, Nagy L. Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration. Nat Immunol 2019;20:626-36. [PMID: 30936495 DOI: 10.1038/s41590-019-0356-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
18 Rappl P, Brüne B, Schmid T. Role of Tristetraprolin in the Resolution of Inflammation. Biology (Basel) 2021;10:66. [PMID: 33477783 DOI: 10.3390/biology10010066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Kholy KE, Genco RJ, Van Dyke TE. Oral infections and cardiovascular disease. Trends in Endocrinology & Metabolism 2015;26:315-21. [DOI: 10.1016/j.tem.2015.03.001] [Cited by in Crossref: 104] [Cited by in F6Publishing: 90] [Article Influence: 14.9] [Reference Citation Analysis]
20 Capuano A, Scavone C, Racagni G, Scaglione F;  Italian Society of Pharmacology. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? Pharmacol Res. 2020;157:104849. [PMID: 32360482 DOI: 10.1016/j.phrs.2020.104849] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
21 Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, Yang R, Uddin J, Guggino WB, Atabani SF. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol. 2004;5:388-392. [PMID: 15034576 DOI: 10.1038/ni1056] [Cited by in Crossref: 243] [Cited by in F6Publishing: 230] [Article Influence: 13.5] [Reference Citation Analysis]
22 Gao Y, Min K, Zhang Y, Su J, Greenwood M, Gronert K. Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease. J Immunol 2015;195:3086-99. [PMID: 26324767 DOI: 10.4049/jimmunol.1500610] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
23 Scott MA, Woolums AR, Swiderski CE, Perkins AD, Nanduri B, Smith DR, Karisch BB, Epperson WB, Blanton JR Jr. Whole blood transcriptomic analysis of beef cattle at arrival identifies potential predictive molecules and mechanisms that indicate animals that naturally resist bovine respiratory disease. PLoS One 2020;15:e0227507. [PMID: 31929561 DOI: 10.1371/journal.pone.0227507] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
24 Corminboeuf O, Leroy X. FPR2/ALXR agonists and the resolution of inflammation. J Med Chem 2015;58:537-59. [PMID: 25365541 DOI: 10.1021/jm501051x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 10.1] [Reference Citation Analysis]
25 Das UN. Clinical Laboratory Tools to Diagnose Inflammation. Advances in Clinical Chemistry Volume 41. Elsevier; 2006. pp. 189-229. [DOI: 10.1016/s0065-2423(05)41006-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
26 White PJ, Arita M, Taguchi R, Kang JX, Marette A. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes 2010;59:3066-73. [PMID: 20841610 DOI: 10.2337/db10-0054] [Cited by in Crossref: 122] [Cited by in F6Publishing: 104] [Article Influence: 10.2] [Reference Citation Analysis]
27 Small M, Serhan CN, Libreros S, Nshimiyimana R. E-series Resolvin Metabolome, Biosynthesis and Critical Role of Stereochemistry of Specialized Pro-Resolving Mediators (SPMs) in Inflammation-Resolution: Preparing SPMs for Long COVID-19, Human Clinical Trials, and Targeted Precision Nutrition. Seminars in Immunology 2022. [DOI: 10.1016/j.smim.2022.101597] [Reference Citation Analysis]
28 Chiang N, Takano T, Arita M, Watanabe S, Serhan CN. A novel rat lipoxin A4 receptor that is conserved in structure and function. Br J Pharmacol 2003;139:89-98. [PMID: 12746227 DOI: 10.1038/sj.bjp.0705220] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
29 Bui P, Imaizumi S, Beedanagari SR, Reddy ST, Hankinson O. Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids. Drug Metab Dispos 2011;39:180-90. [PMID: 21068195 DOI: 10.1124/dmd.110.035121] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
30 Çolakoğlu M, Tunçer S, Banerjee S. Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1. Cell Prolif 2018;51:e12472. [PMID: 30062726 DOI: 10.1111/cpr.12472] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
31 Chen YB, Liu Q, Xie H, Yin SM, Wu L, Yu XH, Fan L, Lin L. Is Chinese Medicine Injection Applicable for Treating Acute Lung Injury and Acute Respiratory Distress Syndrome? A Systematic Review and Meta-analysis of Randomized Controlled Trials. Chin J Integr Med 2020;26:857-66. [PMID: 31776962 DOI: 10.1007/s11655-019-3078-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
32 Wang X, Hjorth E, Vedin I, Eriksdotter M, Freund-Levi Y, Wahlund LO, Cederholm T, Palmblad J, Schultzberg M. Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study. J Lipid Res 2015;56:674-81. [PMID: 25616438 DOI: 10.1194/jlr.P055418] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
33 Mao Y, Ren J, Li J. Regulated spatial distribution of cyclooxygenases and lipoxygenases in Crohn's ulcer. Mediators Inflamm 2006;2006:89581. [PMID: 16951496 DOI: 10.1155/MI/2006/89581] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Maier KL, Alessandrini F, Beck-speier I, Josef Hofer TP, Diabaté S, Bitterle E, Stöger T, Jakob T, Behrendt H, Horsch M, Beckers J, Ziesenis A, Hültner L, Frankenberger M, Krauss-etschmann S, Schulz H. Health Effects of Ambient Particulate Matter—Biological Mechanisms and Inflammatory Responses to In Vitro and In Vivo Particle Exposures. Inhalation Toxicology 2008;20:319-37. [DOI: 10.1080/08958370701866313] [Cited by in Crossref: 107] [Cited by in F6Publishing: 83] [Article Influence: 7.6] [Reference Citation Analysis]
35 Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 2010;107:1170-84. [PMID: 21071715 DOI: 10.1161/CIRCRESAHA.110.223883] [Cited by in Crossref: 266] [Cited by in F6Publishing: 133] [Article Influence: 22.2] [Reference Citation Analysis]
36 Abdulnour RE, Dalli J, Colby JK, Krishnamoorthy N, Timmons JY, Tan SH, Colas RA, Petasis NA, Serhan CN, Levy BD. Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective. Proc Natl Acad Sci U S A 2014;111:16526-31. [PMID: 25369934 DOI: 10.1073/pnas.1407123111] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 12.6] [Reference Citation Analysis]
37 Bennett M, Gilroy DW. Lipid Mediators in Inflammation. Microbiol Spectr 2016;4. [PMID: 27837747 DOI: 10.1128/microbiolspec.MCHD-0035-2016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
38 Doyle R, Sadlier DM, Godson C. Pro-resolving lipid mediators: Agents of anti-ageing? Semin Immunol 2018;40:36-48. [PMID: 30293857 DOI: 10.1016/j.smim.2018.09.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
39 de Gaetano M, Butler E, Gahan K, Zanetti A, Marai M, Chen J, Cacace A, Hams E, Maingot C, Mcloughlin A, Brennan E, Leroy X, Loscher CE, Fallon P, Perretti M, Godson C, Guiry PJ. Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms). European Journal of Medicinal Chemistry 2019;162:80-108. [DOI: 10.1016/j.ejmech.2018.10.049] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
40 Shields AM, Panayi GS, Corrigall VM. Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis? Clin Exp Immunol 2011;165:292-300. [PMID: 21671907 DOI: 10.1111/j.1365-2249.2011.04433.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
41 Nadtochiy SM, Redman EK. Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition 2011;27:733-44. [PMID: 21454053 DOI: 10.1016/j.nut.2010.12.006] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]
42 Fiala M, Terrando N, Dalli J. Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment. J Alzheimers Dis 2015;48:293-301. [PMID: 26401996 DOI: 10.3233/JAD-150367] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
43 Widgerow AD. Cellular resolution of inflammation--catabasis. Wound Repair Regen 2012;20:2-7. [PMID: 22276585 DOI: 10.1111/j.1524-475X.2011.00754.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
44 Martini AC, Forner S, Bento AF, Rae GA. Neuroprotective effects of lipoxin A4 in central nervous system pathologies. Biomed Res Int 2014;2014:316204. [PMID: 25276776 DOI: 10.1155/2014/316204] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
45 Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2014;64:57-80. [PMID: 24320956 DOI: 10.1111/prd.12002] [Cited by in Crossref: 417] [Cited by in F6Publishing: 400] [Article Influence: 59.6] [Reference Citation Analysis]
46 Chen LC, Tseng HM, Kuo ML, Chiu CY, Liao SL, Su KW, Tsai MH, Hua MC, Lai SH, Yao TC, Yeh KW, Wu AH, Huang JL, Huang SK. A composite of exhaled LTB4 , LXA4 , FeNO, and FEV1 as an "asthma classification ratio" characterizes childhood asthma. Allergy 2018;73:627-34. [PMID: 28944471 DOI: 10.1111/all.13318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Bozinovski S, Anthony D, Vlahos R. Targeting pro-resolution pathways to combat chronic inflammation in COPD. J Thorac Dis 2014;6:1548-56. [PMID: 25478196 DOI: 10.3978/j.issn.2072-1439.2014.08.08] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
48 Filep JG, Khreiss T, József L. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005;73:257-62. [DOI: 10.1016/j.plefa.2005.05.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
49 Calder PC. Does Early Exposure to Long Chain Polyunsaturated Fatty Acids Provide Immune Benefits? The Journal of Pediatrics 2010;156:869-71. [DOI: 10.1016/j.jpeds.2010.03.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
50 Regidor PA, Mueller A, Sailer M, Gonzalez Santos F, Rizo JM, Egea FM. Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response. Int J Mol Sci 2020;22:E384. [PMID: 33396555 DOI: 10.3390/ijms22010384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
51 Schett G, Neurath MF. Resolution of chronic inflammatory disease: universal and tissue-specific concepts. Nat Commun 2018;9:3261. [PMID: 30111884 DOI: 10.1038/s41467-018-05800-6] [Cited by in Crossref: 119] [Cited by in F6Publishing: 113] [Article Influence: 29.8] [Reference Citation Analysis]
52 Reynolds MA. Modifiable risk factors in periodontitis: at the intersection of aging and disease. Periodontology 2000 2014;64:7-19. [DOI: 10.1111/prd.12047] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 8.9] [Reference Citation Analysis]
53 Saclier M, Cuvellier S, Magnan M, Mounier R, Chazaud B. Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration. FEBS J. 2013;280:4118-4130. [PMID: 23384231 DOI: 10.1111/febs.12166] [Cited by in Crossref: 145] [Cited by in F6Publishing: 140] [Article Influence: 16.1] [Reference Citation Analysis]
54 Das UN. Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation. J Inflamm Res. 2010;3:143-170. [PMID: 22096364 DOI: 10.2147/jir.s9425] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
55 Yudina Y, Parhamifar L, Bengtsson AM, Juhas M, Sjölander A. Regulation of the eicosanoid pathway by tumour necrosis factor alpha and leukotriene D4 in intestinal epithelial cells. Prostaglandins Leukot Essent Fatty Acids. 2008;79:223-231. [PMID: 19042113 DOI: 10.1016/j.plefa.2008.09.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
56 Deng J, Yang H, Haak VM, Yang J, Kipper FC, Barksdale C, Hwang SH, Gartung A, Bielenberg DR, Subbian S, Ho KK, Ye X, Fan D, Sun Y, Hammock BD, Panigrahy D. Eicosanoid regulation of debris-stimulated metastasis. Proc Natl Acad Sci U S A 2021;118:e2107771118. [PMID: 34607951 DOI: 10.1073/pnas.2107771118] [Reference Citation Analysis]
57 Shelnut EL, Nikas SP, Finnegan DF, Chiang N, Serhan CN, Makriyannis A. Design and synthesis of novel prostaglandin E2 ethanolamide and glycerol ester probes for the putative prostamide receptor(s). Tetrahedron Lett 2015;56:1411-5. [PMID: 25960577 DOI: 10.1016/j.tetlet.2015.01.164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
58 Aid S, Parikh N, Palumbo S, Bosetti F. Neuronal overexpression of cyclooxygenase-2 does not alter the neuroinflammatory response during brain innate immune activation. Neurosci Lett 2010;478:113-8. [PMID: 20451580 DOI: 10.1016/j.neulet.2010.04.076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
59 Innis SM, Pinsk V, Jacobson K. Dietary lipids and intestinal inflammatory disease. The Journal of Pediatrics 2006;149:S89-96. [DOI: 10.1016/j.jpeds.2006.06.058] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
60 von Hegedus JH, Kahnt AS, Ebert R, Heijink M, Toes REM, Giera M, Ioan-Facsinay A. Toll-like receptor signaling induces a temporal switch towards a resolving lipid profile in monocyte-derived macrophages. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158740. [PMID: 32447052 DOI: 10.1016/j.bbalip.2020.158740] [Reference Citation Analysis]
61 Li X, Mazaleuskaya LL, Ballantyne LL, Meng H, FitzGerald GA, Funk CD. Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice. J Lipid Res 2018;59:102-12. [PMID: 29180443 DOI: 10.1194/jlr.M080028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
62 Dubé L, Spahis S, Lachaîne K, Lemieux A, Monhem H, Poulin S, Randoll C, Travaillaud E, Ould-chikh N, Marcil V, Delvin E, Levy E. SPECIALIZED PRO-RESOLVING MEDIATORS DERIVED FROM N-3 POLYUNSATURATED FATTY ACIDS: ROLE IN METABOLIC SYNDROME AND RELATED COMPLICATIONS. Antioxidants & Redox Signaling. [DOI: 10.1089/ars.2021.0156] [Reference Citation Analysis]
63 Chávez-Castillo M, Ortega Á, Cudris-Torres L, Duran P, Rojas M, Manzano A, Garrido B, Salazar J, Silva A, Rojas-Gomez DM, De Sanctis JB, Bermúdez V. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Int J Mol Sci 2021;22:10370. [PMID: 34638711 DOI: 10.3390/ijms221910370] [Reference Citation Analysis]
64 Taketomi Y, Endo Y, Higashi T, Murase R, Ono T, Taya C, Kobayashi T, Murakami M. Mast Cell-Specific Deletion of Group III Secreted Phospholipase A2 Impairs Mast Cell Maturation and Functions. Cells 2021;10:1691. [PMID: 34359862 DOI: 10.3390/cells10071691] [Reference Citation Analysis]
65 Norling LV, Serhan CN. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination. J Intern Med 2010;268:15-24. [PMID: 20497301 DOI: 10.1111/j.1365-2796.2010.02235.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 31] [Article Influence: 0.7] [Reference Citation Analysis]
66 Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J. 2017;31:1273-1288. [PMID: 28087575 DOI: 10.1096/fj.201601222r] [Cited by in Crossref: 282] [Cited by in F6Publishing: 158] [Article Influence: 56.4] [Reference Citation Analysis]
67 Hjorth E, Freund-Levi Y. Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid. Curr Opin Clin Nutr Metab Care 2012;15:134-43. [PMID: 22316559 DOI: 10.1097/MCO.0b013e32835017cc] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
68 Haworth O, Levy BD. Lipoxins, resolvins and protectins: new leads for the treatment of asthma. Expert Opin Drug Discov 2008;3:1209-22. [PMID: 23489078 DOI: 10.1517/17460441.3.10.1209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
69 Shi Z, Ye W, Zhang J, Zhang F, Yu D, Yu H, Chen B, Zhou M, Sun H. LipoxinA4 attenuates acute pancreatitis-associated acute lung injury by regulating AQP-5 and MMP-9 expression, anti-apoptosis and PKC/SSeCKS-mediated F-actin activation. Mol Immunol. 2018;103:78-88. [PMID: 30219663 DOI: 10.1016/j.molimm.2018.09.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
70 Romano M, Luciotti G, Gangemi S, Marinucci F, Prontera C, D'Urbano E, Davì G. Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins. Lab Invest 2002;82:1253-4. [PMID: 12218086 DOI: 10.1097/01.lab.0000028823.53486.4a] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
71 Ariel A, Li P, Wang W, Tang W, Fredman G, Hong S, Gotlinger KH, Serhan CN. The Docosatriene Protectin D1 Is Produced by TH2 Skewing and Promotes Human T Cell Apoptosis via Lipid Raft Clustering. Journal of Biological Chemistry 2005;280:43079-86. [DOI: 10.1074/jbc.m509796200] [Cited by in Crossref: 166] [Cited by in F6Publishing: 89] [Article Influence: 9.8] [Reference Citation Analysis]
72 Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621. [PMID: 20192811 DOI: 10.1146/annurev-immunol-030409-101225] [Cited by in Crossref: 1228] [Cited by in F6Publishing: 1209] [Article Influence: 102.3] [Reference Citation Analysis]
73 Fournier BM, Parkos CA. The role of neutrophils during intestinal inflammation. Mucosal Immunol 2012;5:354-66. [DOI: 10.1038/mi.2012.24] [Cited by in Crossref: 320] [Cited by in F6Publishing: 311] [Article Influence: 32.0] [Reference Citation Analysis]
74 Calder PC. Fatty acids and immune function: relevance to inflammatory bowel diseases. Int Rev Immunol 2009;28:506-34. [PMID: 19954361 DOI: 10.3109/08830180903197480] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
75 Kalsotra A, Du L, Wang Y, Ladd PA, Kikuta Y, Duvic M, Boyd AS, Keeney DS, Strobel HW. Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways. FASEB J 2008;22:538-47. [PMID: 17884973 DOI: 10.1096/fj.07-9244com] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
76 Bannenberg G, Moussignac RL, Gronert K, Devchand PR, Schmidt BA, Guilford WJ, Bauman JG, Subramanyam B, Perez HD, Parkinson JF, Serhan CN. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br J Pharmacol 2004;143:43-52. [PMID: 15302682 DOI: 10.1038/sj.bjp.0705912] [Cited by in Crossref: 94] [Cited by in F6Publishing: 85] [Article Influence: 5.2] [Reference Citation Analysis]
77 Kantarci A, Van Dyke TE. Lipoxin signaling in neutrophils and their role in periodontal disease. Prostaglandins Leukot Essent Fatty Acids 2005;73:289-99. [PMID: 15979867 DOI: 10.1016/j.plefa.2005.05.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
78 Johansson M, Denardo DG, Coussens LM. Polarized immune responses differentially regulate cancer development. Immunol Rev. 2008;222:145-154. [PMID: 18363999 DOI: 10.1111/j.1600-065x.2008.00600.x] [Cited by in Crossref: 137] [Cited by in F6Publishing: 75] [Article Influence: 10.5] [Reference Citation Analysis]
79 Holen E, He J, Espe M, Chen L, Araujo P. Combining eicosapentaenoic acid, decosahexaenoic acid and arachidonic acid, using a fully crossed design, affect gene expression and eicosanoid secretion in salmon head kidney cells in vitro. Fish Shellfish Immunol 2015;45:695-703. [PMID: 26003739 DOI: 10.1016/j.fsi.2015.05.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
80 Bonnans C, Fukunaga K, Levy MA, Levy BD. Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. Am J Pathol 2006;168:1064-72. [PMID: 16565483 DOI: 10.2353/ajpath.2006.051056] [Cited by in Crossref: 98] [Cited by in F6Publishing: 96] [Article Influence: 6.1] [Reference Citation Analysis]
81 Dalli J. Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections? Mol Aspects Med 2017;58:12-20. [PMID: 28365269 DOI: 10.1016/j.mam.2017.03.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
82 Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015;27:200-215. [PMID: 25857211 DOI: 10.1016/j.smim.2015.03.004] [Cited by in Crossref: 310] [Cited by in F6Publishing: 283] [Article Influence: 44.3] [Reference Citation Analysis]
83 Arita M. Mediator lipidomics in acute inflammation and resolution. J Biochem. 2012;152:313-319. [PMID: 22923733 DOI: 10.1093/jb/mvs092] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 9.5] [Reference Citation Analysis]
84 Nevius E, Srivastava PK, Basu S. Oral ingestion of Capsaicin, the pungent component of chili pepper, enhances a discreet population of macrophages and confers protection from autoimmune diabetes. Mucosal Immunol 2012;5:76-86. [DOI: 10.1038/mi.2011.50] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
85 Laurent P, Jolivel V, Manicki P, Chiu L, Contin-Bordes C, Truchetet ME, Pradeu T. Immune-Mediated Repair: A Matter of Plasticity. Front Immunol 2017;8:454. [PMID: 28484454 DOI: 10.3389/fimmu.2017.00454] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
86 Chaitidis P, Kreutzer FJ, Gerth C, Janata P, Kühn H. Impact of intravenous oxygen therapy on the expression of reticulocyte-type 15-lipoxygenase in human volunteers. Prostaglandins Leukot Essent Fatty Acids 2004;71:271-6. [PMID: 15380813 DOI: 10.1016/j.plefa.2004.03.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
87 Mowry FE, Biancardi VC. Neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways. Pharmacol Res 2019;144:279-91. [PMID: 31039397 DOI: 10.1016/j.phrs.2019.04.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
88 Ji J, Fan J. Neutrophil in Reverse Migration: Role in Sepsis. Front Immunol 2021;12:656039. [PMID: 33790916 DOI: 10.3389/fimmu.2021.656039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Carlo T, Kalwa H, Levy BD. 15-Epi-lipoxin A4 inhibits human neutrophil superoxide anion generation by regulating polyisoprenyl diphosphate phosphatase 1. FASEB J 2013;27:2733-41. [PMID: 23568778 DOI: 10.1096/fj.12-223982] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
90 Kulkarni OP, Lichtnekert J, Anders HJ, Mulay SR. The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is "Inflammation" Always Inflammation? Mediators Inflamm 2016;2016:2856213. [PMID: 27597803 DOI: 10.1155/2016/2856213] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
91 Norling LV, Perretti M. Control of myeloid cell trafficking in resolution. J Innate Immun 2013;5:367-76. [PMID: 23635943 DOI: 10.1159/000350612] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
92 Serhan CN. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. Journal of Thrombosis and Haemostasis 2009;7:44-8. [DOI: 10.1111/j.1538-7836.2009.03396.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 7.0] [Reference Citation Analysis]
93 Das UN. Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? Front Endocrinol (Lausanne) 2017;8:182. [PMID: 28824543 DOI: 10.3389/fendo.2017.00182] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
94 Havixbeck JJ, Barreda DR. Neutrophil Development, Migration, and Function in Teleost Fish. Biology (Basel) 2015;4:715-34. [PMID: 26561837 DOI: 10.3390/biology4040715] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
95 Fullerton JN, O'Brien AJ, Gilroy DW. Lipid mediators in immune dysfunction after severe inflammation. Trends Immunol 2014;35:12-21. [PMID: 24268519 DOI: 10.1016/j.it.2013.10.008] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
96 De Kock M, Loix S, Lavand'homme P. Ketamine and peripheral inflammation. CNS Neurosci Ther 2013;19:403-10. [PMID: 23574634 DOI: 10.1111/cns.12104] [Cited by in Crossref: 99] [Cited by in F6Publishing: 84] [Article Influence: 11.0] [Reference Citation Analysis]
97 Chattopadhyay R, Raghavan S, Rao GN. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function. Redox Biol 2017;12:438-55. [PMID: 28319894 DOI: 10.1016/j.redox.2017.02.023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
98 Barnig C, Levy BD. Innate immunity is a key factor for the resolution of inflammation in asthma. Eur Respir Rev 2015;24:141-53. [PMID: 25726564 DOI: 10.1183/09059180.00012514] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
99 Chan SS, Luben R, Bergmann MM, Boeing H, Olsen A, Tjonneland A, Overvad K, Kaaks R, Kennedy H, Khaw KT, Riboli E, Hart AR. Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study. Aliment Pharmacol Ther 2011;34:649-55. [PMID: 21790683 DOI: 10.1111/j.1365-2036.2011.04784.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
100 Carlo T, Levy BD. Molecular circuits of resolution in airway inflammation. ScientificWorldJournal 2010;10:1386-99. [PMID: 20623098 DOI: 10.1100/tsw.2010.143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
101 Sorokin AV, Norris PC, English JT, Dey AK, Chaturvedi A, Baumer Y, Silverman J, Playford MP, Serhan CN, Mehta NN. Identification of proresolving and inflammatory lipid mediators in human psoriasis. J Clin Lipidol 2018;12:1047-60. [PMID: 29730187 DOI: 10.1016/j.jacl.2018.03.091] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
102 Jim MC, Hung ND, Yoo JM, Kim MR, Sok D. Suppressive effect of docosahexaenoyl‐lysophosphatidylcholine and 17‐hydroxydocosahexaenoyl‐lysophosphatidylcholine on levels of cytokines in spleen of mice treated with lipopolysaccharide. Eur J Lipid Sci Technol 2012;114:114-22. [DOI: 10.1002/ejlt.201100169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
103 Sur R, Babad JM, Garay M, Liebel FT, Southall MD. Anti-Inflammatory Activity of Sertaconazole Nitrate Is Mediated via Activation of a p38–COX-2–PGE2 Pathway. Journal of Investigative Dermatology 2008;128:336-44. [DOI: 10.1038/sj.jid.5700972] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
104 Kantarci A, Van Dyke TE. Resolution of inflammation in periodontitis. J Periodontol 2005;76:2168-74. [PMID: 16277590 DOI: 10.1902/jop.2005.76.11-S.2168] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
105 Shang P, Zhang Y, Ma D, Hao Y, Wang X, Xin M, Zhang Y, Zhu M, Feng J. Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases. Expert Opin Ther Targets 2019;23:967-86. [PMID: 31711309 DOI: 10.1080/14728222.2019.1691525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
106 Dakin SG, Dudhia J, Smith RK. Resolving an inflammatory concept: the importance of inflammation and resolution in tendinopathy. Vet Immunol Immunopathol 2014;158:121-7. [PMID: 24556326 DOI: 10.1016/j.vetimm.2014.01.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
107 Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 2016;16:51-67. [PMID: 26688348 DOI: 10.1038/nri.2015.4] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 35.7] [Reference Citation Analysis]
108 Childs CE, Romeu-nadal M, Burdge GC, Calder PC. Gender differences in the n -3 fatty acid content of tissues. Proc Nutr Soc 2008;67:19-27. [DOI: 10.1017/s0029665108005983] [Cited by in Crossref: 145] [Cited by in F6Publishing: 56] [Article Influence: 10.4] [Reference Citation Analysis]
109 Hyvärinen K, Holopainen M, Skirdenko V, Ruhanen H, Lehenkari P, Korhonen M, Käkelä R, Laitinen S, Kerkelä E. Mesenchymal Stromal Cells and Their Extracellular Vesicles Enhance the Anti-Inflammatory Phenotype of Regulatory Macrophages by Downregulating the Production of Interleukin (IL)-23 and IL-22. Front Immunol 2018;9:771. [PMID: 29706969 DOI: 10.3389/fimmu.2018.00771] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
110 Britt RD Jr, Velten M, Tipple TE, Nelin LD, Rogers LK. Cyclooxygenase-2 in newborn hyperoxic lung injury. Free Radic Biol Med 2013;61:502-11. [PMID: 23624331 DOI: 10.1016/j.freeradbiomed.2013.04.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
111 Sigurdardottir SL, Freysdottir J, Vikingsdottir T, Valdimarsson H, Vikingsson A. Do non-steroidal anti-inflammatory drugs influence chronic inflammation? The effects of piroxicam on chronic antigen-induced arthritis in rats. Scand J Rheumatol. 2008;37:469-476. [PMID: 19005999 DOI: 10.1080/03009740802225876] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
112 Campbell EL, MacManus CF, Kominsky DJ, Keely S, Glover LE, Bowers BE, Scully M, Bruyninckx WJ, Colgan SP. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc Natl Acad Sci USA. 2010;107:14298-14303. [PMID: 20660763 DOI: 10.1073/pnas.0914730107] [Cited by in Crossref: 127] [Cited by in F6Publishing: 116] [Article Influence: 10.6] [Reference Citation Analysis]
113 Moos PJ, Edes K, Cassidy P, Massuda E, Fitzpatrick F. Electrophilic Prostaglandins and Lipid Aldehydes Repress Redox-sensitive Transcription Factors p53 and Hypoxia-inducible Factor by Impairing the Selenoprotein Thioredoxin Reductase. Journal of Biological Chemistry 2003;278:745-50. [DOI: 10.1074/jbc.m211134200] [Cited by in Crossref: 128] [Cited by in F6Publishing: 45] [Article Influence: 6.7] [Reference Citation Analysis]
114 Zhu M, Wang X, Sun L, Schultzberg M, Hjorth E. Can inflammation be resolved in Alzheimer's disease? Ther Adv Neurol Disord 2018;11:1756286418791107. [PMID: 30116300 DOI: 10.1177/1756286418791107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
115 Sezin T, Ferreirós N, Jennrich M, Ochirbold K, Seutter M, Attah C, Mousavi S, Zillikens D, Geisslinger G, Sadik CD. 12/15-Lipoxygenase choreographs the resolution of IgG-mediated skin inflammation. Journal of Autoimmunity 2020;115:102528. [DOI: 10.1016/j.jaut.2020.102528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Blaudez F, Ivanovski S, Fournier B, Vaquette C. The utilisation of resolvins in medicine and tissue engineering. Acta Biomater 2021:S1742-7061(21)00803-5. [PMID: 34875358 DOI: 10.1016/j.actbio.2021.11.047] [Reference Citation Analysis]
117 Magdalon J, Vinolo MAR, Rodrigues HG, Paschoal VA, Torres RP, Mancini-filho J, Calder PC, Hatanaka E, Curi R. Oral Administration of Oleic or Linoleic Acids Modulates the Production of Inflammatory Mediators by Rat Macrophages. Lipids 2012;47:803-12. [DOI: 10.1007/s11745-012-3687-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
118 Smallwood TB, Giacomin PR, Loukas A, Mulvenna JP, Clark RJ, Miles JJ. Helminth Immunomodulation in Autoimmune Disease. Front Immunol 2017;8:453. [PMID: 28484453 DOI: 10.3389/fimmu.2017.00453] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 20.2] [Reference Citation Analysis]
119 Abma W, Noreby M, Wheelock CE, Dahlén SE, Adner M, Säfholm J. Lipoxin A4 reduces house dust mite and TNFα-induced hyperreactivity in the mouse trachea. Prostaglandins Other Lipid Mediat 2020;149:106428. [PMID: 32070748 DOI: 10.1016/j.prostaglandins.2020.106428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Gilroy DW, Colville-Nash PR, McMaster S, Sawatzky DA, Willoughby DA, Lawrence T. Inducible cyclooxygenase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. FASEB J 2003;17:2269-71. [PMID: 14563690 DOI: 10.1096/fj.02-1162fje] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 5.8] [Reference Citation Analysis]
121 Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan L, Van Dyke TE. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003;171:6856-65. [PMID: 14662892 DOI: 10.4049/jimmunol.171.12.6856] [Cited by in Crossref: 289] [Cited by in F6Publishing: 271] [Article Influence: 16.1] [Reference Citation Analysis]
122 Cioccari L, Luethi N, Masoodi M. Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine. Front Immunol 2020;11:599853. [PMID: 33324417 DOI: 10.3389/fimmu.2020.599853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Fang X, Abbott J, Cheng L, Colby JK, Lee JW, Levy BD, Matthay MA. Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4. J Immunol. 2015;195:875-881. [PMID: 26116507 DOI: 10.4049/jimmunol.1500244] [Cited by in Crossref: 93] [Cited by in F6Publishing: 93] [Article Influence: 13.3] [Reference Citation Analysis]
124 Lee YY, Wong CKC, Oger C, Durand T, Galano J, Lee JC. Prenatal exposure to the contaminant perfluorooctane sulfonate elevates lipid peroxidation during mouse fetal development but not in the pregnant dam. Free Radical Research 2015;49:1015-25. [DOI: 10.3109/10715762.2015.1027199] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
125 Devassy JG, Leng S, Gabbs M, Monirujjaman M, Aukema HM. Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. Adv Nutr 2016;7:905-16. [PMID: 27633106 DOI: 10.3945/an.116.012187] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 9.5] [Reference Citation Analysis]
126 Al-Salahi RA, Gamal-Eldeen AM, Alanazi AM, Al-Omar MA, Marzouk MA, Fouda MM. Cytotoxicity and anti-inflammatory activity of methylsulfanyl-triazoloquinazolines. Molecules 2013;18:1434-46. [PMID: 23348996 DOI: 10.3390/molecules18021434] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
127 Bannenberg GL, Aliberti J, Hong S, Sher A, Serhan C. Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis. J Exp Med 2004;199:515-23. [PMID: 14970178 DOI: 10.1084/jem.20031325] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
128 Dorow J, Becker S, Kortz L, Thiery J, Hauschildt S, Ceglarek U. Preanalytical Investigation of Polyunsaturated Fatty Acids and Eicosanoids in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry. Biopreserv Biobank 2016;14:107-13. [PMID: 26886177 DOI: 10.1089/bio.2015.0005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
129 Scimone ML, Lutzky VP, Zittermann SI, Maffia P, Jancic C, Buzzola F, Issekutz AC, Chuluyan HE. Migration of polymorphonuclear leucocytes is influenced by dendritic cells. Immunology 2005;114:375-85. [PMID: 15720439 DOI: 10.1111/j.1365-2567.2005.02104.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
130 Brancaleone V, Dalli J, Bena S, Flower RJ, Cirino G, Perretti M. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature. J Immunol 2011;186:4905-14. [PMID: 21398608 DOI: 10.4049/jimmunol.1003145] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
131 Spite M, Clària J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 2014;19:21-36. [PMID: 24239568 DOI: 10.1016/j.cmet.2013.10.006] [Cited by in Crossref: 261] [Cited by in F6Publishing: 247] [Article Influence: 29.0] [Reference Citation Analysis]
132 Hisada T, Ishizuka T, Aoki H, Mori M. Resolvin E1 as a novel agent for the treatment of asthma. Expert Opin Ther Targets 2009;13:513-22. [PMID: 19368495 DOI: 10.1517/14728220902865622] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
133 Das UN. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis. 2008;7:37. [PMID: 18922179 DOI: 10.1186/1476-511x-7-37] [Cited by in Crossref: 132] [Cited by in F6Publishing: 57] [Article Influence: 9.4] [Reference Citation Analysis]
134 Il Lee S, Zuo X, Shureiqi I. 15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in? Cancer Metastasis Rev 2011;30:481-91. [PMID: 22037943 DOI: 10.1007/s10555-011-9321-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
135 Fattori V, Zaninelli TH, Rasquel-Oliveira FS, Casagrande R, Verri WA Jr. Specialized pro-resolving lipid mediators: A new class of non-immunosuppressive and non-opioid analgesic drugs. Pharmacol Res 2020;151:104549. [PMID: 31743775 DOI: 10.1016/j.phrs.2019.104549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
136 Siegel ER, Croze RH, Fang X, Matthay MA, Gotts JE. Inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice. Am J Physiol Lung Cell Mol Physiol 2021;320:L1085-92. [PMID: 33822656 DOI: 10.1152/ajplung.00046.2021] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
137 Mattos MS, Lopes ME, de Araujo AM, Alvarenga DM, Nakagaki BN, Mafra K, de Miranda CDM, Diniz AB, Antunes MM, Lopes MAF, Rezende RM, Menezes GB. Prolonged neutrophil survival at necrotic sites is a fundamental feature for tissue recovery and resolution of hepatic inflammation. J Leukoc Biol 2020;108:1199-213. [PMID: 32422690 DOI: 10.1002/JLB.1MA0420-634R] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Natto ZS, Yaghmoor W, Alshaeri HK, Van Dyke TE. Omega-3 Fatty Acids Effects on Inflammatory Biomarkers and Lipid Profiles among Diabetic and Cardiovascular Disease Patients: A Systematic Review and Meta-Analysis. Sci Rep 2019;9:18867. [PMID: 31827125 DOI: 10.1038/s41598-019-54535-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
139 Oh SF, Pillai PS, Recchiuti A, Yang R, Serhan CN. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J Clin Invest. 2011;121:569-581. [PMID: 21206090 DOI: 10.1172/jci42545] [Cited by in Crossref: 186] [Cited by in F6Publishing: 120] [Article Influence: 16.9] [Reference Citation Analysis]
140 Guan S, Jia B, Chao K, Zhu X, Tang J, Li M, Wu L, Xing L, Liu K, Zhang L, Wang X, Gao X, Huang M. UPLC–QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis. J Proteome Res 2020;19:600-9. [DOI: 10.1021/acs.jproteome.9b00440] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
141 Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2:355-374. [PMID: 22254027 DOI: 10.3390/nu2030355] [Cited by in Crossref: 409] [Cited by in F6Publishing: 371] [Article Influence: 34.1] [Reference Citation Analysis]
142 Zhu J, Kilty I, Granger H, Gamble E, Qiu YS, Hattotuwa K, Elston W, Liu WL, Oliva A, Pauwels RA, Kips JC, De Rose V, Barnes N, Yeadon M, Jenkinson S, Jeffery PK. Gene expression and immunolocalization of 15-lipoxygenase isozymes in the airway mucosa of smokers with chronic bronchitis. Am J Respir Cell Mol Biol 2002;27:666-77. [PMID: 12444026 DOI: 10.1165/rcmb.4820] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
143 Moisan E, Chiasson S, Girard D. The intriguing normal acute inflammatory response in mice lacking vimentin. Clin Exp Immunol 2007;150:158-68. [PMID: 17680824 DOI: 10.1111/j.1365-2249.2007.03460.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
144 Bruegel M, Ceglarek U, Thiery J. Eicosanoids: essential mediators in health and disease / Eicosanoide: bedeutende Faktoren in der Homöostase und ihre Bedeutung in der Pathogenese multipler Erkrankungen. LaboratoriumsMedizin 2009;33:333-9. [DOI: 10.1515/jlm.2009.056] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
145 Ungaro F, D'Alessio S, Danese S. The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies. Cancers (Basel) 2020;12:E2060. [PMID: 32722560 DOI: 10.3390/cancers12082060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
146 Bang S, Yoo S, Yang TJ, Cho H, Hwang SW. 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. Br J Pharmacol 2012;165:683-92. [PMID: 21718307 DOI: 10.1111/j.1476-5381.2011.01568.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 9.4] [Reference Citation Analysis]
147 Meng H, Liu Y, Lai L. Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation. Acc Chem Res 2015;48:2242-50. [PMID: 26237215 DOI: 10.1021/acs.accounts.5b00226] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
148 Kühn H, O'Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 2006;45:334-356. [PMID: 16678271 DOI: 10.1016/j.plipres.2006.02.003] [Cited by in Crossref: 267] [Cited by in F6Publishing: 253] [Article Influence: 16.7] [Reference Citation Analysis]
149 Calder PC. Long-chain polyunsaturated fatty acids and inflammation. Scandinavian Journal of Food and Nutrition 2016;50:54-61. [DOI: 10.1080/17482970601066389] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
150 Fischer CD, Duquette SC, Renaux BS, Feener TD, Morck DW, Hollenberg MD, Lucas MJ, Buret AG. Tulathromycin exerts proresolving effects in bovine neutrophils by inhibiting phospholipases and altering leukotriene B4, prostaglandin E2, and lipoxin A4 production. Antimicrob Agents Chemother 2014;58:4298-307. [PMID: 24820086 DOI: 10.1128/AAC.02813-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
151 Serhan CN. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. Prostaglandins Leukot Essent Fatty Acids. 2008;79:157-163. [PMID: 19008087 DOI: 10.1016/j.plefa.2008.09.012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
152 Hanna VS, Hafez EAA. Synopsis of arachidonic acid metabolism: A review. J Adv Res 2018;11:23-32. [PMID: 30034873 DOI: 10.1016/j.jare.2018.03.005] [Cited by in Crossref: 153] [Cited by in F6Publishing: 134] [Article Influence: 38.3] [Reference Citation Analysis]
153 Uderhardt S, Krönke G. 12/15-lipoxygenase during the regulation of inflammation, immunity, and self-tolerance. J Mol Med (Berl) 2012;90:1247-56. [PMID: 22983484 DOI: 10.1007/s00109-012-0954-4] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 5.6] [Reference Citation Analysis]
154 Eun JC, Moore EE, Banerjee A, Kelher MR, Khan SY, Elzi DJ, McLaughlin NJ, Silliman CC. Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells. Shock 2011;35:240-4. [PMID: 20926984 DOI: 10.1097/SHK.0b013e3181faceb3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
155 Nijmeh J, Levy BD. Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDS. Cell Biochem Biophys 2021. [PMID: 34176102 DOI: 10.1007/s12013-021-01012-w] [Reference Citation Analysis]
156 Syeda MM, Jing X, Mirza RH, Yu H, Sellers RS, Chi Y. Prostaglandin transporter modulates wound healing in diabetes by regulating prostaglandin-induced angiogenesis. Am J Pathol 2012;181:334-46. [PMID: 22609345 DOI: 10.1016/j.ajpath.2012.03.012] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
157 Robb CT, Regan KH, Dorward DA, Rossi AG. Key mechanisms governing resolution of lung inflammation. Semin Immunopathol 2016;38:425-48. [PMID: 27116944 DOI: 10.1007/s00281-016-0560-6] [Cited by in Crossref: 120] [Cited by in F6Publishing: 105] [Article Influence: 20.0] [Reference Citation Analysis]
158 Pino AM, Rodríguez JP. Is fatty acid composition of human bone marrow significant to bone health? Bone 2019;118:53-61. [DOI: 10.1016/j.bone.2017.12.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
159 Ariel A, Chiang N, Arita M, Petasis NA, Serhan CN. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J Immunol 2003;170:6266-72. [PMID: 12794159 DOI: 10.4049/jimmunol.170.12.6266] [Cited by in Crossref: 125] [Cited by in F6Publishing: 120] [Article Influence: 6.6] [Reference Citation Analysis]
160 Hage C, Michaëlsson E, Linde C, Donal E, Daubert JC, Gan LM, Lund LH. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach. Circ Cardiovasc Genet 2017;10:e001633. [PMID: 28100627 DOI: 10.1161/CIRCGENETICS.116.001633] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 9.4] [Reference Citation Analysis]
161 Ji RR, Xu ZZ, Strichartz G, Serhan CN. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 2011;34:599-609. [PMID: 21963090 DOI: 10.1016/j.tins.2011.08.005] [Cited by in Crossref: 207] [Cited by in F6Publishing: 198] [Article Influence: 18.8] [Reference Citation Analysis]
162 Yang A, Wu Y, Yu G, Wang H. Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development. Respir Res 2021;22:204. [PMID: 34261470 DOI: 10.1186/s12931-021-01792-y] [Reference Citation Analysis]
163 Laubach K, Zhang J, Chen X. The p53 Family: A Role in Lipid and Iron Metabolism. Front Cell Dev Biol 2021;9:715974. [PMID: 34395447 DOI: 10.3389/fcell.2021.715974] [Reference Citation Analysis]
164 Chen CM, Lu HC, Tung YT, Chen W. Antiplatelet Therapy for Acute Respiratory Distress Syndrome. Biomedicines 2020;8:E230. [PMID: 32708068 DOI: 10.3390/biomedicines8070230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
165 Cakin MC, Ozdemir B, Kaya-Dagistanli F, Arkan H, Bahtiyar N, Anapali M, Akbas F, Onaran I. Evaluation of the in vivo wound healing potential of the lipid fraction from activated platelet-rich plasma. Platelets 2020;31:513-20. [PMID: 31524041 DOI: 10.1080/09537104.2019.1663805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
166 Lee Y, Choo J, Kim SJ, Heo G, Pothoulakis C, Kim YH, Im E. Analysis of endogenous lipids during intestinal wound healing. PLoS One 2017;12:e0183028. [PMID: 28800645 DOI: 10.1371/journal.pone.0183028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
167 Zahoor I, Giri S. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis. Clin Rev Allergy Immunol 2021;60:147-63. [PMID: 32495237 DOI: 10.1007/s12016-020-08796-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
168 Philippe R, Urbach V. Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis. Int J Mol Sci 2018;19:E2865. [PMID: 30241412 DOI: 10.3390/ijms19102865] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
169 Stamatakis K, Pérez-Sala D. Prostanoids with cyclopentenone structure as tools for the characterization of electrophilic lipid-protein interactomes. Ann N Y Acad Sci 2006;1091:548-70. [PMID: 17341644 DOI: 10.1196/annals.1378.096] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
170 Zhang H, Lu Y, Sun G, Teng F, Luo N, Jiang J, Wen A. The common promoter polymorphism rs11666254 downregulates FPR2/ALX expression and increases risk of sepsis in patients with severe trauma. Crit Care 2017;21:171. [PMID: 28679406 DOI: 10.1186/s13054-017-1757-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
171 Levy BD. Resolvins and protectins: natural pharmacophores for resolution biology. Prostaglandins Leukot Essent Fatty Acids 2010;82:327-32. [PMID: 20227865 DOI: 10.1016/j.plefa.2010.02.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 5.7] [Reference Citation Analysis]
172 Yates CM, Calder PC, Ed Rainger G. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacology & Therapeutics 2014;141:272-82. [DOI: 10.1016/j.pharmthera.2013.10.010] [Cited by in Crossref: 212] [Cited by in F6Publishing: 188] [Article Influence: 26.5] [Reference Citation Analysis]
173 Divangahi M, Behar SM, Remold H. Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis. Adv Exp Med Biol 2013;783:103-20. [PMID: 23468106 DOI: 10.1007/978-1-4614-6111-1_6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 8.3] [Reference Citation Analysis]
174 de Carvalho CCCR, Caramujo MJ. The Various Roles of Fatty Acids. Molecules 2018;23:E2583. [PMID: 30304860 DOI: 10.3390/molecules23102583] [Cited by in Crossref: 90] [Cited by in F6Publishing: 68] [Article Influence: 22.5] [Reference Citation Analysis]
175 Aliberti J, Bafica A. Anti-inflammatory pathways as a host evasion mechanism for pathogens. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005;73:283-8. [DOI: 10.1016/j.plefa.2005.05.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
176 He C, Wu Y, Lai Y, Cai Z, Liu Y, Lai L. Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network. Mol BioSyst 2012;8:1585. [DOI: 10.1039/c2mb05503a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
177 Cho HK, Cheong KJ, Kim HY, Cheong J. Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4. Biochem J. 2011;435:431-439. [PMID: 21244365 DOI: 10.1042/bj20102071] [Cited by in Crossref: 57] [Cited by in F6Publishing: 36] [Article Influence: 5.2] [Reference Citation Analysis]
178 Rodgers K, McMahon B, Mitchell D, Sadlier D, Godson C. Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells. Am J Pathol 2005;167:683-94. [PMID: 16127149 DOI: 10.1016/S0002-9440(10)62043-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
179 Motohashi E, Kawauchi H, Endo H, Kondo H, Kitasato H, Kuramoto H, Majima M, Unno N, Hayashi I. Regulatory expression of lipoxin A4 receptor in physiologically estrus cycle and pathologically endometriosis. Biomed Pharmacother 2005;59:330-8. [PMID: 15996849 DOI: 10.1016/j.biopha.2005.05.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
180 Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008;52:885-897. [PMID: 18504706 DOI: 10.1002/mnfr.200700289] [Cited by in Crossref: 293] [Cited by in F6Publishing: 268] [Article Influence: 20.9] [Reference Citation Analysis]
181 Benabdoune H, Rondon EP, Shi Q, Fernandes J, Ranger P, Fahmi H, Benderdour M. The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. Inflamm Res 2016;65:635-45. [PMID: 27056390 DOI: 10.1007/s00011-016-0946-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
182 Van Anh TT, Mostafa A, Rao Z, Pace S, Schwaiger S, Kretzer C, Temml V, Giesel C, Jordan PM, Bilancia R, Weinigel C, Rummler S, Waltenberger B, Hung T, Rossi A, Stuppner H, Werz O, Koeberle A. From Vietnamese plants to a biflavonoid that relieves inflammation by triggering the lipid mediator class switch to resolution. Acta Pharm Sin B 2021;11:1629-47. [PMID: 34221873 DOI: 10.1016/j.apsb.2021.04.011] [Reference Citation Analysis]
183 German JB, Yeritzian C, Tolstoguzov VB. Olfaction, where Nutrition, Memory and Immunity Intersect. In: Berger RG, editor. Flavours and Fragrances. Berlin: Springer Berlin Heidelberg; 2007. pp. 25-41. [DOI: 10.1007/978-3-540-49339-6_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
184 Casati S, Giannasi C, Niada S, Bergamaschi RF, Orioli M, Brini AT. Bioactive Lipids in MSCs Biology: State of the Art and Role in Inflammation. Int J Mol Sci 2021;22:1481. [PMID: 33540695 DOI: 10.3390/ijms22031481] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
185 Zhang G, Liu X, Wang W, Cai Y, Li S, Chen Q, Liao M, Zhang M, Zeng G, Zhou B, Feng CG, Chen X. Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophages. Cell Cycle 2016;15:2527-38. [PMID: 27494776 DOI: 10.1080/15384101.2016.1215386] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
186 Goligorsky MS. Immune system in renal injury and repair: burning the candle from both ends? Pharmacol Res 2008;58:122-8. [PMID: 18588980 DOI: 10.1016/j.phrs.2008.05.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
187 Perretti M, Ingegnoli F, Wheller SK, Blades MC, Solito E, Pitzalis C. Annexin 1 modulates monocyte-endothelial cell interaction in vitro and cell migration in vivo in the human SCID mouse transplantation model. J Immunol 2002;169:2085-92. [PMID: 12165536 DOI: 10.4049/jimmunol.169.4.2085] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
188 Dietzold J, Gopalakrishnan A, Salgame P. Duality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad cop. F1000Prime Rep 2015;7:29. [PMID: 25926980 DOI: 10.12703/P7-29] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
189 Koeberle A, Werz O. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders. Biochem Pharmacol. 2015;98:1-15. [PMID: 26123522 DOI: 10.1016/j.bcp.2015.06.022] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 11.0] [Reference Citation Analysis]
190 Park GY, Christman JW. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol 2006;290:L797-805. [PMID: 16603593 DOI: 10.1152/ajplung.00513.2005] [Cited by in Crossref: 118] [Cited by in F6Publishing: 117] [Article Influence: 7.4] [Reference Citation Analysis]
191 Calder PC. Fatty acids and inflammation: The cutting edge between food and pharma. European Journal of Pharmacology 2011;668:S50-8. [DOI: 10.1016/j.ejphar.2011.05.085] [Cited by in Crossref: 286] [Cited by in F6Publishing: 252] [Article Influence: 26.0] [Reference Citation Analysis]
192 Chiang N, Serhan CN. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med 2017;58:114-29. [PMID: 28336292 DOI: 10.1016/j.mam.2017.03.005] [Cited by in Crossref: 138] [Cited by in F6Publishing: 134] [Article Influence: 27.6] [Reference Citation Analysis]
193 Marino M, Masella R, Bulzomi P, Campesi I, Malorni W, Franconi F. Nutrition and human health from a sex-gender perspective. Mol Aspects Med 2011;32:1-70. [PMID: 21356234 DOI: 10.1016/j.mam.2011.02.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
194 Gilroy DW, Newson J, Sawmynaden P, Willoughby DA, Croxtall JD. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J. 2004;18:489-498. [PMID: 15003994 DOI: 10.1096/fj.03-0837com] [Cited by in Crossref: 127] [Cited by in F6Publishing: 122] [Article Influence: 7.1] [Reference Citation Analysis]
195 Pitts MG, D'Orazio SEF. Prostaglandin E2 Inhibits the Ability of Neutrophils to Kill Listeria monocytogenes. J Immunol 2019;202:3474-82. [PMID: 31061007 DOI: 10.4049/jimmunol.1900201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
196 Mackel JJ, Garth JM, Blackburn JP, Jones M, Steele C. 12/15-Lipoxygenase Deficiency Impairs Neutrophil Granulopoiesis and Lung Proinflammatory Responses to Aspergillus fumigatus. J Immunol 2020;204:1849-58. [PMID: 32102903 DOI: 10.4049/jimmunol.1900808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
197 Taylor AL, Bonventre JV, Uliasz TF, Hewett JA, Hewett SJ. Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death. J Neurochem 2008;106:1828-40. [PMID: 18564366 DOI: 10.1111/j.1471-4159.2008.05527.x] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
198 Levy BD, Serhan CN. Resolution of acute inflammation in the lung. Annu Rev Physiol 2014;76:467-92. [PMID: 24313723 DOI: 10.1146/annurev-physiol-021113-170408] [Cited by in Crossref: 168] [Cited by in F6Publishing: 151] [Article Influence: 18.7] [Reference Citation Analysis]
199 Dakin SG, Smith RK, Heinegård D, Önnerfjord P, Khabut A, Dudhia J. Proteomic analysis of tendon extracellular matrix reveals disease stage-specific fragmentation and differential cleavage of COMP (cartilage oligomeric matrix protein). J Biol Chem 2014;289:4919-27. [PMID: 24398684 DOI: 10.1074/jbc.M113.511972] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
200 Alvarenga DM, Mattos MS, Lopes ME, Marchesi SC, Araújo AM, Nakagaki BN, Santos MM, David BA, De Souza VA, Carvalho É, Sousa Pereira RV, Marques PE, Mafra K, de Castro Oliveira HM, de Miranda CDM, Diniz AB, de Oliveira THC, Teixeira MM, Rezende RM, Antunes MM, Menezes GB. Paradoxical Role of Matrix Metalloproteinases in Liver Injury and Regeneration after Sterile Acute Hepatic Failure. Cells 2018;7:E247. [PMID: 30563238 DOI: 10.3390/cells7120247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
201 Chiang N, Schwab JM, Fredman G, Kasuga K, Gelman S, Serhan CN. Anesthetics impact the resolution of inflammation. PLoS One 2008;3:e1879. [PMID: 18382663 DOI: 10.1371/journal.pone.0001879] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
202 Norling LV, Dalli J, Flower RJ, Serhan CN, Perretti M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol 2012;32:1970-8. [PMID: 22499990 DOI: 10.1161/ATVBAHA.112.249508] [Cited by in Crossref: 166] [Cited by in F6Publishing: 124] [Article Influence: 16.6] [Reference Citation Analysis]
203 Gravaghi C, La Perle KM, Ogrodwski P, Kang JX, Quimby F, Lipkin M, Lamprecht SA. Cox-2 expression, PGE(2) and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice. J Nutr Biochem. 2011;22:360-365. [PMID: 20655721 DOI: 10.1016/j.jnutbio.2010.03.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
204 Calder PC. Long-chain fatty acids and inflammation. Proc Nutr Soc 2012;71:284-9. [DOI: 10.1017/s0029665112000067] [Cited by in Crossref: 100] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
205 Prescott D, McKay DM. Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production. Am J Physiol Gastrointest Liver Physiol. 2011;301:G487-G497. [PMID: 21659618 DOI: 10.1152/ajpgi.00042.2011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
206 Guimarães FR, Sales-campos H, Nardini V, da Costa TA, Fonseca MTC, Júnior VR, Sorgi CA, da Silva JS, Chica JEL, Faccioli LH, de Barros Cardoso CR. The inhibition of 5-Lipoxygenase (5-LO) products leukotriene B4 (LTB 4 ) and cysteinyl leukotrienes (cysLTs) modulates the inflammatory response and improves cutaneous wound healing. Clinical Immunology 2018;190:74-83. [DOI: 10.1016/j.clim.2017.08.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
207 Ganea D, Kocieda V, Kong W, Yen JH. Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation. Clin Lipidol 2011;6:277-91. [PMID: 21804863 DOI: 10.2217/clp.11.12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
208 Ağış ER, Savaş B, Melli M. Impact of colonic mucosal lipoxin A4 synthesis capacity on healing in rats with dextran sodium sulfate-induced colitis. Prostaglandins & Other Lipid Mediators 2015;121:63-9. [DOI: 10.1016/j.prostaglandins.2015.04.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
209 Bodhale N, Ohms M, Ferreira C, Mesquita I, Mukherjee A, André S, Sarkar A, Estaquier J, Laskay T, Saha B, Silvestre R. Cytokines and metabolic regulation: A framework of bidirectional influences affecting Leishmania infection. Cytokine 2021;147:155267. [PMID: 32917471 DOI: 10.1016/j.cyto.2020.155267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
210 Li Y, Dalli J, Chiang N, Baron RM, Quintana C, Serhan CN. Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators. Immunity 2013;39:885-98. [PMID: 24238341 DOI: 10.1016/j.immuni.2013.10.011] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 11.0] [Reference Citation Analysis]
211 Decker Y, McBean G, Godson C. Lipoxin A4 inhibits IL-1beta-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells. Am J Physiol Cell Physiol 2009;296:C1420-7. [PMID: 19357230 DOI: 10.1152/ajpcell.00380.2008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
212 Maderna P, Godson C. Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells. Prostaglandins Leukot Essent Fatty Acids 2005;73:179-87. [PMID: 15978792 DOI: 10.1016/j.plefa.2005.05.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
213 Ungaro F, Rubbino F, Danese S, D'Alessio S. Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases. Front Immunol 2017;8:1331. [PMID: 29109724 DOI: 10.3389/fimmu.2017.01331] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
214 Odaka C, Mizuochi T, Yang J, Ding A. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response. J Immunol 2003;171:1507-14. [PMID: 12874244 DOI: 10.4049/jimmunol.171.3.1507] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 3.7] [Reference Citation Analysis]
215 Moges R, De Lamache DD, Sajedy S, Renaux BS, Hollenberg MD, Muench G, Abbott EM, Buret AG. Anti-Inflammatory Benefits of Antibiotics: Tylvalosin Induces Apoptosis of Porcine Neutrophils and Macrophages, Promotes Efferocytosis, and Inhibits Pro-Inflammatory CXCL-8, IL1α, and LTB4 Production, While Inducing the Release of Pro-Resolving Lipoxin A4 and Resolvin D1. Front Vet Sci 2018;5:57. [PMID: 29696149 DOI: 10.3389/fvets.2018.00057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
216 Homann J, Suo J, Schmidt M, de Bruin N, Scholich K, Geisslinger G, Ferreirós N. In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse. PLoS One 2015;10:e0143141. [PMID: 26599340 DOI: 10.1371/journal.pone.0143141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
217 Planaguma A, Levy BD. Uncontrolled airway inflammation in lung disease represents a defect in counter-regulatory signaling. Future Lipidol 2008;3:697-704. [PMID: 19293940 DOI: 10.2217/17460875.3.6.697] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
218 An J, Hong S, Oh D. Regiospecificity of a novel bacterial lipoxygenase from Myxococcus xanthus for polyunsaturated fatty acids. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2018;1863:823-33. [DOI: 10.1016/j.bbalip.2018.04.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
219 Calder PC. n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. The American Journal of Clinical Nutrition 2006;83:1505S-19S. [DOI: 10.1093/ajcn/83.6.1505s] [Cited by in Crossref: 1536] [Cited by in F6Publishing: 552] [Article Influence: 96.0] [Reference Citation Analysis]
220 Fu T, Mohan M, Brennan EP, Woodman OL, Godson C, Kantharidis P, Ritchie RH, Qin CX. Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease. ACS Pharmacol Transl Sci 2020;3:43-55. [PMID: 32259087 DOI: 10.1021/acsptsci.9b00097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
221 Kourtzelis I, Hajishengallis G, Chavakis T. Phagocytosis of Apoptotic Cells in Resolution of Inflammation. Front Immunol 2020;11:553. [PMID: 32296442 DOI: 10.3389/fimmu.2020.00553] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
222 Levy BD. Myocardial 15-Epi-lipoxin A 4 Generation Provides a New Mechanism for the Immunomodulatory Effects of Statins and Thiazolidinediones. Circulation 2006;114:873-5. [DOI: 10.1161/circulationaha.106.647925] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
223 Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol. 2008;153 Suppl 1:S200-S215. [PMID: 17965751 DOI: 10.1038/sj.bjp.0707489] [Cited by in Crossref: 217] [Cited by in F6Publishing: 235] [Article Influence: 14.5] [Reference Citation Analysis]
224 Hutchinson JL, Rajagopal SP, Sales KJ, Jabbour HN. Molecular regulators of resolution of inflammation: potential therapeutic targets in the reproductive system. REPRODUCTION 2011;142:15-28. [DOI: 10.1530/rep-11-0069] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
225 Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 2005;174:4345-55. [PMID: 15778399 DOI: 10.4049/jimmunol.174.7.4345] [Cited by in Crossref: 479] [Cited by in F6Publishing: 456] [Article Influence: 28.2] [Reference Citation Analysis]
226 Kantarci A, Van Dyke TE. Lipoxins in chronic inflammation. Crit Rev Oral Biol Med 2003;14:4-12. [PMID: 12764016 DOI: 10.1177/154411130301400102] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
227 Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 2008;3:279-312. [PMID: 18233953 DOI: 10.1146/annurev.pathmechdis.3.121806.151409] [Cited by in Crossref: 338] [Cited by in F6Publishing: 311] [Article Influence: 24.1] [Reference Citation Analysis]
228 Otoki Y, Metherel AH, Pedersen T, Yang J, Hammock BD, Bazinet RP, Newman JW, Taha AY. Acute Hypercapnia/Ischemia Alters the Esterification of Arachidonic Acid and Docosahexaenoic Acid Epoxide Metabolites in Rat Brain Neutral Lipids. Lipids 2020;55:7-22. [PMID: 31691988 DOI: 10.1002/lipd.12197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
229 Nandivada P, Cowan E, Carlson SJ, Chang M, Gura KM, Puder M. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease. Prostaglandins Leukot Essent Fatty Acids 2013;89:153-8. [PMID: 23602846 DOI: 10.1016/j.plefa.2013.02.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
230 Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat 2002;68-69:433-55. [PMID: 12432935 DOI: 10.1016/s0090-6980(02)00047-3] [Cited by in Crossref: 131] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
231 Hung ND, Kim MR, Sok D. Oral Administration of 2-Docosahexaenoyl Lysophosphatidylcholine Displayed Anti-Inflammatory Effects on Zymosan A-Induced Peritonitis. Inflammation 2011;34:147-60. [DOI: 10.1007/s10753-010-9218-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
232 Lee JY, Jung YW, Jeong I, Joh JS, Sim SY, Choi B, Jee HG, Lim DG. Immune parameters differentiating active from latent tuberculosis infection in humans. Tuberculosis (Edinb) 2015;95:758-63. [PMID: 26520601 DOI: 10.1016/j.tube.2015.08.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
233 Sonnweber T, Pizzini A, Nairz M, Weiss G, Tancevski I. Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases. Int J Mol Sci 2018;19:E3285. [PMID: 30360467 DOI: 10.3390/ijms19113285] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 19.5] [Reference Citation Analysis]
234 Dalli J, Serhan C. Macrophage Proresolving Mediators-the When and Where. Microbiol Spectr 2016;4. [PMID: 27337457 DOI: 10.1128/microbiolspec.MCHD-0001-2014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
235 Poorani R, Bhatt AN, Dwarakanath B, Das UN. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance. European Journal of Pharmacology 2016;785:116-32. [DOI: 10.1016/j.ejphar.2015.08.049] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 10.8] [Reference Citation Analysis]
236 Serhan CN. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biol 2004;122:305-21. [PMID: 15322859 DOI: 10.1007/s00418-004-0695-8] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 6.1] [Reference Citation Analysis]
237 Maskrey BH, Megson IL, Whitfield PD, Rossi AG. Mechanisms of Resolution of Inflammation: A Focus on Cardiovascular Disease. ATVB 2011;31:1001-6. [DOI: 10.1161/atvbaha.110.213850] [Cited by in Crossref: 101] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
238 Buechler C, Pohl R, Aslanidis C. Pro-Resolving Molecules-New Approaches to Treat Sepsis? Int J Mol Sci 2017;18:E476. [PMID: 28241480 DOI: 10.3390/ijms18030476] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
239 Kong D, Shen Y, Liu G, Zuo S, Ji Y, Lu A, Nakamura M, Lazarus M, Stratakis CA, Breyer RM, Yu Y. PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation. J Exp Med 2016;213:2209-26. [PMID: 27621415 DOI: 10.1084/jem.20160459] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
240 Hadley KB, Ryan AS, Forsyth S, Gautier S, Salem N Jr. The Essentiality of Arachidonic Acid in Infant Development. Nutrients 2016;8:216. [PMID: 27077882 DOI: 10.3390/nu8040216] [Cited by in Crossref: 160] [Cited by in F6Publishing: 133] [Article Influence: 26.7] [Reference Citation Analysis]
241 Serhan CN, Levy B. Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics. Proc Natl Acad Sci U S A 2003;100:8609-11. [PMID: 12861081 DOI: 10.1073/pnas.1733589100] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 3.5] [Reference Citation Analysis]
242 Ferrer RA, Saalbach A, Grünwedel M, Lohmann N, Forstreuter I, Saupe S, Wandel E, Simon JC, Franz S. Dermal Fibroblasts Promote Alternative Macrophage Activation Improving Impaired Wound Healing. Journal of Investigative Dermatology 2017;137:941-50. [DOI: 10.1016/j.jid.2016.11.035] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
243 Isobe Y, Kato T, Arita M. Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation. Front Immunol 2012;3:270. [PMID: 22973272 DOI: 10.3389/fimmu.2012.00270] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
244 Zhai B, Yang H, Mancini A, He Q, Antoniou J, Di Battista JA. Leukotriene B(4) BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras/Raf/ERK/p42 AUF1 pathway. J Biol Chem 2010;285:23568-80. [PMID: 20489206 DOI: 10.1074/jbc.M110.107623] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
245 Lee H, Surh Y. Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders. Biochemical Pharmacology 2012;84:1340-50. [DOI: 10.1016/j.bcp.2012.08.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
246 Pillai PS, Leeson S, Porter TF, Owens CD, Kim JM, Conte MS, Serhan CN, Gelman S. Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients. Inflammation 2012;35:98-113. [PMID: 21286796 DOI: 10.1007/s10753-011-9294-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
247 Das UN. Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. Prostaglandins Leukot Essent Fatty Acids 2013;88:201-10. [PMID: 23295193 DOI: 10.1016/j.plefa.2012.11.009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
248 Körner A, Zhou E, Müller C, Mohammed Y, Herceg S, Bracher F, Rensen PCN, Wang Y, Mirakaj V, Giera M. Inhibition of Δ24-dehydrocholesterol reductase activates pro-resolving lipid mediator biosynthesis and inflammation resolution. Proc Natl Acad Sci U S A 2019;116:20623-34. [PMID: 31548397 DOI: 10.1073/pnas.1911992116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
249 Onali S, Favale A, Fantini MC. The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. Cells 2019;8:E344. [PMID: 30979024 DOI: 10.3390/cells8040344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
250 Demarquoy J, Borgne FL. Biosynthesis, metabolism and function of protectins and resolvins. Clinical Lipidology 2014;9:683-93. [DOI: 10.2217/clp.14.44] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
251 Serhan CN. Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiol Clin 2006;24:341-64. [PMID: 16927933 DOI: 10.1016/j.atc.2006.01.003] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
252 Uriarte SM, Edmisson JS, Jimenez-Flores E. Human neutrophils and oral microbiota: a constant tug-of-war between a harmonious and a discordant coexistence. Immunol Rev 2016;273:282-98. [PMID: 27558341 DOI: 10.1111/imr.12451] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 10.2] [Reference Citation Analysis]
253 Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2006;75:197-202. [PMID: 16828270 DOI: 10.1016/j.plefa.2006.05.012] [Cited by in Crossref: 335] [Cited by in F6Publishing: 289] [Article Influence: 20.9] [Reference Citation Analysis]
254 Roy S, Das A, Sen CK. Disorder of Localized Inflammation in Wound Healing: A Systems Perspective. In: Vodovotz Y, An G, editors. Complex Systems and Computational Biology Approaches to Acute Inflammation. New York: Springer; 2013. pp. 173-83. [DOI: 10.1007/978-1-4614-8008-2_10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
255 Devchand PR, Arita M, Hong S, Bannenberg G, Moussignac R, Gronert K, Serhan CN. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB j 2003;17:652-9. [DOI: 10.1096/fj.02-0770com] [Cited by in Crossref: 136] [Cited by in F6Publishing: 119] [Article Influence: 7.2] [Reference Citation Analysis]
256 Simões R, Niconi-de-almeida Y, da-Fé A, Barja-fidalgo C, Fierro I. A synthetic analog of 15-epi-lipoxin A4 inhibits human monocyte apoptosis: Involvement of ERK-2 and PI3-kinase. Prostaglandins & Other Lipid Mediators 2010;91:10-7. [DOI: 10.1016/j.prostaglandins.2009.12.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
257 Tani Y, Isobe Y, Imoto Y, Segi-Nishida E, Sugimoto Y, Arai H, Arita M. Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice. FASEB J 2014;28:4036-43. [PMID: 24891522 DOI: 10.1096/fj.14-251132] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
258 Svensson CI, Zattoni M, Serhan CN. Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J Exp Med 2007;204:245-52. [PMID: 17242163 DOI: 10.1084/jem.20061826] [Cited by in Crossref: 122] [Cited by in F6Publishing: 112] [Article Influence: 8.1] [Reference Citation Analysis]
259 Jose S, Madan R. Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections. Anaerobe 2016;41:85-90. [PMID: 27063896 DOI: 10.1016/j.anaerobe.2016.04.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
260 Pérez-Novo CA, Claeys C, Van Zele T, Holtapples G, Van Cauwenberge P, Bachert C. Eicosanoid metabolism and eosinophilic inflammation in nasal polyp patients with immune response to Staphylococcus aureus enterotoxins. Am J Rhinol 2006;20:456-60. [PMID: 16955779 DOI: 10.2500/ajr.2006.20.2873] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
261 Biteman B, Hassan IR, Walker E, Leedom AJ, Dunn M, Seta F, Laniado-Schwartzman M, Gronert K. Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J 2007;21:2257-66. [PMID: 17384141 DOI: 10.1096/fj.06-7918com] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 4.3] [Reference Citation Analysis]
262 Sachdeva S, Saluja H, Mani A, Phadnaik MB, Mani S. Lipoxins in inflammation. Clin Hemorheol Microcirc 2022. [PMID: 35147530 DOI: 10.3233/CH-211346] [Reference Citation Analysis]
263 Yang J, Schmelzer K, Georgi K, Hammock BD. Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Chem 2009;81:8085-93. [PMID: 19715299 DOI: 10.1021/ac901282n] [Cited by in Crossref: 236] [Cited by in F6Publishing: 231] [Article Influence: 18.2] [Reference Citation Analysis]
264 Ke Y, Zebda N, Oskolkova O, Afonyushkin T, Berdyshev E, Tian Y, Meng F, Sarich N, Bochkov VN, Wang JM, Birukova AA, Birukov KG. Anti-Inflammatory Effects of OxPAPC Involve Endothelial Cell-Mediated Generation of LXA4. Circ Res 2017;121:244-57. [PMID: 28522438 DOI: 10.1161/CIRCRESAHA.116.310308] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
265 Das UN. Lipoxins as biomarkers of lupus and other inflammatory conditions. Lipids Health Dis. 2011;10:76. [PMID: 21569625 DOI: 10.1186/1476-511x-10-76] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
266 Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med 2017;58:1-11. [PMID: 28263773 DOI: 10.1016/j.mam.2017.03.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 20.6] [Reference Citation Analysis]
267 Serhan CN, Hong S, Lu Y. Lipid mediator informatics-lipidomics: novel pathways in mapping resolution. AAPS J 2006;8:E284-97. [PMID: 16796379 DOI: 10.1007/BF02854899] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
268 Dakin SG, Werling D, Hibbert A, Abayasekara DR, Young NJ, Smith RK, Dudhia J. Macrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repair. PLoS One 2012;7:e32333. [PMID: 22384219 DOI: 10.1371/journal.pone.0032333] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
269 Kowal K, Gielicz A, Sanak M. The effect of allergen-induced bronchoconstriction on concentration of 5-oxo-ETE in exhaled breath condensate of house dust mite-allergic patients. Clin Exp Allergy 2017;47:1253-62. [PMID: 28763131 DOI: 10.1111/cea.12990] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
270 Qiu F, Devchand PR, Wada K, Serhan CN. Aspirin‐triggered lipoxin A 4 and lipoxin A 4 up‐regulate transcriptional corepressor NAB1 in human neutrophils. FASEB j 2001;15:1-18. [DOI: 10.1096/fj.01-0576fje] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
271 Wu B, Capilato J, Pham MP, Walker J, Spur B, Rodriguez A, Perez LJ, Yin K. Lipoxin A4 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition. FASEB J 2016;30:2400-10. [PMID: 26965685 DOI: 10.1096/fj.201500029R] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
272 Maksymowych WP, Wichuk S, Chiowchanwisawakit P, Lambert RG, Pedersen SJ. Fat Metaplasia and Backfill Are Key Intermediaries in the Development of Sacroiliac Joint Ankylosis in Patients With Ankylosing Spondylitis: Development of SI Joint Ankylosis in Patients With AS. Arthritis & Rheumatology 2014;66:2958-67. [DOI: 10.1002/art.38792] [Cited by in Crossref: 79] [Cited by in F6Publishing: 62] [Article Influence: 9.9] [Reference Citation Analysis]
273 Das UN. A defect in the activity of Delta6 and Delta5 desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007;76:251-68. [PMID: 17466497 DOI: 10.1016/j.plefa.2007.03.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
274 Haworth O, Buckley CD. Resolving the problem of persistence in the switch from acute to chronic inflammation. Proc Natl Acad Sci U S A 2007;104:20647-8. [PMID: 18093938 DOI: 10.1073/pnas.0710633105] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
275 Tsai WH, Chang SC, Lin YC, Hsu HC. CX3CL1(+) Microparticles-Induced MFG-E8 Enhances Apoptotic Cell Clearance by Alveolar Macrophages. Cells 2021;10:2583. [PMID: 34685562 DOI: 10.3390/cells10102583] [Reference Citation Analysis]
276 Das UN. Albumin to globulin ratio and/or plasma albumin in predicting long-term mortality. Am J Surg 2014;208:157-8. [PMID: 24524861 DOI: 10.1016/j.amjsurg.2013.08.055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
277 Pyrillou K, Chairakaki AD, Tamvakopoulos C, Andreakos E. Dexamethasone induces ω3-derived immunoresolvents driving resolution of allergic airway inflammation. J Allergy Clin Immunol 2018;142:691-695.e4. [PMID: 29698628 DOI: 10.1016/j.jaci.2018.04.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
278 Lima-Garcia JF, Dutra RC, da Silva K, Motta EM, Campos MM, Calixto JB. The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. Br J Pharmacol 2011;164:278-93. [PMID: 21418187 DOI: 10.1111/j.1476-5381.2011.01345.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 126] [Article Influence: 13.4] [Reference Citation Analysis]
279 Calder PC, Kremmyda L, Vlachava M, Noakes PS, Miles EA. Is there a role for fatty acids in early life programming of the immune system? Proc Nutr Soc 2010;69:373-80. [DOI: 10.1017/s0029665110001552] [Cited by in Crossref: 86] [Cited by in F6Publishing: 29] [Article Influence: 7.2] [Reference Citation Analysis]
280 Rocha-Gregg B, Huttenlocher A. Signal integration in forward and reverse neutrophil migration: Fundamentals and emerging mechanisms. Curr Opin Cell Biol 2021;72:124-30. [PMID: 34411839 DOI: 10.1016/j.ceb.2021.07.002] [Reference Citation Analysis]
281 Zaninelli TH, Fattori V, Verri WA Jr. Harnessing Inflammation Resolution in Arthritis: Current Understanding of Specialized Pro-resolving Lipid Mediators' Contribution to Arthritis Physiopathology and Future Perspectives. Front Physiol 2021;12:729134. [PMID: 34539449 DOI: 10.3389/fphys.2021.729134] [Reference Citation Analysis]
282 Kroon EE, Coussens AK, Kinnear C, Orlova M, Möller M, Seeger A, Wilkinson RJ, Hoal EG, Schurr E. Neutrophils: Innate Effectors of TB Resistance? Front Immunol 2018;9:2637. [PMID: 30487797 DOI: 10.3389/fimmu.2018.02637] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
283 Lukashev DE, Ohta A, Sitkovsky MV. Physiological regulation of acute inflammation by A2A adenosine receptor. Drug Dev Res 2005;64:172-7. [DOI: 10.1002/ddr.10428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
284 Dakin SG. A review of the healing processes in equine superficial digital flexor tendinopathy. Equine Vet Educ 2017;29:516-20. [DOI: 10.1111/eve.12572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
285 Van Dyke TE. The management of inflammation in periodontal disease. J Periodontol 2008;79:1601-8. [PMID: 18673016 DOI: 10.1902/jop.2008.080173] [Cited by in Crossref: 146] [Cited by in F6Publishing: 128] [Article Influence: 10.4] [Reference Citation Analysis]
286 Layé S, Nadjar A, Joffre C, Bazinet RP. Anti-Inflammatory Effects of Omega-3 Fatty Acids in the Brain: Physiological Mechanisms and Relevance to Pharmacology. Pharmacol Rev 2018;70:12-38. [PMID: 29217656 DOI: 10.1124/pr.117.014092] [Cited by in Crossref: 157] [Cited by in F6Publishing: 129] [Article Influence: 31.4] [Reference Citation Analysis]
287 Varol A, Seifert O, Anderson CD. The skin pathergy test: innately useful? Arch Dermatol Res. 2010;302:155-168. [PMID: 20012749 DOI: 10.1007/s00403-009-1008-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
288 Weinberger B, Quizon C, Vetrano AM, Archer F, Laskin JD, Laskin DL. Mechanisms mediating reduced responsiveness of neonatal neutrophils to lipoxin A4. Pediatr Res 2008;64:393-8. [PMID: 18535486 DOI: 10.1203/PDR.0b013e318180e4af] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
289 Britt RD, Locy ML, Tipple TE, Nelin LD, Rogers LK. Lipopolysaccharide-induced cyclooxygenase-2 expression in mouse transformed Clara cells. Cell Physiol Biochem. 2012;29:213-222. [PMID: 22415090 DOI: 10.1159/000337602] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
290 Serhan CN, Chiang N, Dalli J. Macrophages and the Entrance of Resolution Phase Lipid Mediators. In: Biswas SK, Mantovani A, editors. Macrophages: Biology and Role in the Pathology of Diseases. New York: Springer; 2014. pp. 287-314. [DOI: 10.1007/978-1-4939-1311-4_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
291 Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 2021;6:263. [PMID: 34248142 DOI: 10.1038/s41392-021-00658-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
292 Rhodes LE, Gledhill K, Masoodi M, Haylett AK, Brownrigg M, Thody AJ, Tobin DJ, Nicolaou A. The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J 2009;23:3947-56. [PMID: 19584301 DOI: 10.1096/fj.09-136077] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 6.8] [Reference Citation Analysis]
293 Mitchell D, O'Meara SJ, Gaffney A, Crean JK, Kinsella BT, Godson C. The Lipoxin A4 receptor is coupled to SHP-2 activation: implications for regulation of receptor tyrosine kinases. J Biol Chem 2007;282:15606-18. [PMID: 17403678 DOI: 10.1074/jbc.M611004200] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
294 Insuela DBR, Ferrero MR, Coutinho DS, Martins MA, Carvalho VF. Could Arachidonic Acid-Derived Pro-Resolving Mediators Be a New Therapeutic Strategy for Asthma Therapy? Front Immunol 2020;11:580598. [PMID: 33362766 DOI: 10.3389/fimmu.2020.580598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
295 Vuletic S, Taylor BA, Tofler GH, Chait A, Marcovina SM, Schenck K, Albers JJ. SAA and PLTP activity in plasma of periodontal patients before and after full-mouth tooth extraction. Oral Dis 2008;14:514-9. [PMID: 18826383 DOI: 10.1111/j.1601-0825.2007.01411.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
296 Celebi D, Aydin P, Cinar I, Kutlu Z, Calik I, Halici Z, Bilici D, Bayraktutan Z. Protective effect of luteolin on acute lung injury in a rat model of sepsis. Biotech Histochem 2020;:1-7. [PMID: 33176504 DOI: 10.1080/10520295.2020.1846787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
297 Guimarães RC, Gonçalves TT, Leiria LO. Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases. Br J Pharmacol 2021;178:531-49. [PMID: 33169375 DOI: 10.1111/bph.15321] [Reference Citation Analysis]
298 Tahan F, Saraymen R, Gumus H. The role of lipoxin A4 in exercise-induced bronchoconstriction in asthma. J Asthma 2008;45:161-4. [PMID: 18350409 DOI: 10.1080/02770900701847068] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
299 Whatling C, McPheat W, Herslöf M. The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field. Expert Opin Investig Drugs 2007;16:1879-93. [PMID: 18041998 DOI: 10.1517/13543784.16.12.1879] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
300 Sitkovsky MV, Ohta A. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol. 2005;26:299-304. [PMID: 15922945 DOI: 10.1016/j.it.2005.04.004] [Cited by in Crossref: 192] [Cited by in F6Publishing: 187] [Article Influence: 11.3] [Reference Citation Analysis]
301 Tyurina YY, Tyurin VA, Anthonymuthu T, Amoscato AA, Sparvero LJ, Nesterova AM, Baynard ML, Sun W, He R, Khaitovich P, Vladimirov YA, Gabrilovich DI, Bayır H, Kagan VE. "Redox lipidomics technology: Looking for a needle in a haystack". Chem Phys Lipids 2019;221:93-107. [PMID: 30928338 DOI: 10.1016/j.chemphyslip.2019.03.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
302 Park J, Langmead CJ, Riddy DM. New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery. ACS Pharmacol Transl Sci 2020;3:88-106. [PMID: 32259091 DOI: 10.1021/acsptsci.9b00075] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
303 Kawamura M, Tada Y, Kadoya Y, Obata S, Harada Y. COX-2 expression in stromal fibroblasts self-limits their numbers in lymph node inflammatory responses. Prostaglandins Other Lipid Mediat 2013;106:79-90. [PMID: 23587942 DOI: 10.1016/j.prostaglandins.2013.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
304 Conte MS, Desai TA, Wu B, Schaller M, Werlin E. Pro-resolving lipid mediators in vascular disease. J Clin Invest 2018;128:3727-35. [PMID: 30168805 DOI: 10.1172/JCI97947] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 6.8] [Reference Citation Analysis]
305 Beck-Speier I, Karg E, Behrendt H, Stoeger T, Alessandrini F. Ultrafine particles affect the balance of endogenous pro- and anti-inflammatory lipid mediators in the lung: in-vitro and in-vivo studies. Part Fibre Toxicol 2012;9:27. [PMID: 22809365 DOI: 10.1186/1743-8977-9-27] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
306 Maxis K, Delalandre A, Martel-Pelletier J, Pelletier JP, Duval N, Lajeunesse D. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein. Arthritis Res Ther 2006;8:R181. [PMID: 17156456 DOI: 10.1186/ar2092] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
307 Hasturk H, Kantarci A, Van Dyke TE. Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol 2012;3:118. [PMID: 22623923 DOI: 10.3389/fimmu.2012.00118] [Cited by in Crossref: 79] [Cited by in F6Publishing: 88] [Article Influence: 7.9] [Reference Citation Analysis]
308 Stefanson A, Bakovic M. Dietary polyacetylene falcarinol upregulated intestinal heme oxygenase-1 and modified plasma cytokine profile in late phase lipopolysaccharide-induced acute inflammation in CB57BL/6 mice. Nutr Res 2020;80:89-105. [PMID: 32738564 DOI: 10.1016/j.nutres.2020.06.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
309 Mazaleuskaya LL, Lawson JA, Li X, Grant G, Mesaros C, Grosser T, Blair IA, Ricciotti E, FitzGerald GA. A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood. JCI Insight 2016;1:e87031. [PMID: 27547824 DOI: 10.1172/jci.insight.87031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
310 Serhan CN, de la Rosa X, Jouvene C. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation. J Intern Med 2019;286:240-58. [PMID: 30565762 DOI: 10.1111/joim.12871] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
311 Kim W, Lee HN, Jang JH, Kim SH, Lee YH, Hahn YI, Ngo HK, Choi Y, Joe Y, Chung HT, Chen Y, Cha YN, Surh YJ. 15-Deoxy-Δ12,14-Prostaglandin J2 Exerts Proresolving Effects Through Nuclear Factor E2-Related Factor 2-Induced Expression of CD36 and Heme Oxygenase-1. Antioxid Redox Signal 2017;27:1412-31. [PMID: 28398824 DOI: 10.1089/ars.2016.6754] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
312 Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev 2011;111:5922-43. [PMID: 21766791 DOI: 10.1021/cr100396c] [Cited by in Crossref: 607] [Cited by in F6Publishing: 560] [Article Influence: 55.2] [Reference Citation Analysis]
313 Archambault AS, Turcotte C, Martin C, Provost V, Larose MC, Laprise C, Chakir J, Bissonnette É, Laviolette M, Bossé Y, Flamand N. Comparison of eight 15-lipoxygenase (LO) inhibitors on the biosynthesis of 15-LO metabolites by human neutrophils and eosinophils. PLoS One 2018;13:e0202424. [PMID: 30118527 DOI: 10.1371/journal.pone.0202424] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
314 Stopka-farooqui U, Haworth O. Proresolving mediators: new therapies to treat inflammatory diseases. Clinical Lipidology 2015;10:343-50. [DOI: 10.2217/clp.15.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
315 Gao L, Yu Q, Zhang H, Wang Z, Zhang T, Xiang J, Yu S, Zhang S, Wu H, Xu Y, Wang Z, Shen L, Shu G, Chen YG, Liu H, Shen L, Li B. A resident stromal cell population actively restrains innate immune response in the propagation phase of colitis pathogenesis in mice. Sci Transl Med 2021;13:eabb5071. [PMID: 34290057 DOI: 10.1126/scitranslmed.abb5071] [Reference Citation Analysis]
316 Meital LT, Sandow SL, Calder PC, Russell FD. Abdominal aortic aneurysm and omega-3 polyunsaturated fatty acids: Mechanisms, animal models, and potential treatment. Prostaglandins Leukot Essent Fatty Acids 2017;118:1-9. [PMID: 28288701 DOI: 10.1016/j.plefa.2017.02.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
317 Perucci LO, Sugimoto MA, Gomes KB, Dusse LM, Teixeira MM, Sousa LP. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. Expert Opin Ther Targets 2017;21:879-96. [PMID: 28786708 DOI: 10.1080/14728222.2017.1364363] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
318 Vong L, Ferraz JG, Panaccione R, Beck PL, Wallace JL. A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. Proc Natl Acad Sci USA. 2010;107:12023-12027. [PMID: 20547854 DOI: 10.1073/pnas.1004982107] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
319 Kremmyda LS, Vlachava M, Noakes PS, Diaper ND, Miles EA, Calder PC. Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review. Clin Rev Allergy Immunol 2011;41:36-66. [PMID: 19997989 DOI: 10.1007/s12016-009-8186-2] [Cited by in Crossref: 127] [Cited by in F6Publishing: 102] [Article Influence: 11.5] [Reference Citation Analysis]
320 Levy B. Lipoxins and lipoxin analogs in asthma. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005;73:231-7. [DOI: 10.1016/j.plefa.2005.05.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
321 Tam VC. Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections. Semin Immunol 2013;25:240-8. [PMID: 24084369 DOI: 10.1016/j.smim.2013.08.006] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 7.1] [Reference Citation Analysis]
322 Quiros M, Nusrat A. Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair. Trends Mol Med 2019;25:124-35. [PMID: 30642681 DOI: 10.1016/j.molmed.2018.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
323 Carion TW, Greenwood M, Ebrahim AS, Jerome A, Suvas S, Gronert K, Berger EA. Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis. FASEB J 2018;32:5026-38. [PMID: 29913556 DOI: 10.1096/fj.201701502R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
324 Gangemi S, Luciotti G, D'Urbano E, Mallamace A, Santoro D, Bellinghieri G, Davi G, Romano M. Physical exercise increases urinary excretion of lipoxin A4 and related compounds. J Appl Physiol (1985) 2003;94:2237-40. [PMID: 12588790 DOI: 10.1152/japplphysiol.01004.2002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
325 Briottet M, Shum M, Urbach V. The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease. Front Pharmacol 2020;11:1290. [PMID: 32982730 DOI: 10.3389/fphar.2020.01290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
326 Gagliardo R, Gras D, La Grutta S, Chanez P, Di Sano C, Albano GD, Vachier I, Montalbano AM, Anzalone G, Bonanno A, Riccobono L, Gjomarkaj M, Profita M. Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma. J Allergy Clin Immunol 2016;137:1796-806. [PMID: 26971688 DOI: 10.1016/j.jaci.2015.11.045] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
327 Kim AS, Conte MS. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy. Advanced Drug Delivery Reviews 2020;159:170-9. [DOI: 10.1016/j.addr.2020.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
328 Signorini C, De Felice C, Durand T, Galano J, Oger C, Leoncini S, Hayek J, Lee JC, Lund TC, Orchard PJ. Isoprostanoid Plasma Levels Are Relevant to Cerebral Adrenoleukodystrophy Disease. Life 2022;12:146. [DOI: 10.3390/life12020146] [Reference Citation Analysis]
329 Lukashev D, Ohta A, Apasov S, Chen J, Sitkovsky M. Cutting Edge: Physiologic Attenuation of Proinflammatory Transcription by the G s Protein-Coupled A2A Adenosine Receptor In Vivo. J Immunol 2004;173:21-4. [DOI: 10.4049/jimmunol.173.1.21] [Cited by in Crossref: 119] [Cited by in F6Publishing: 114] [Article Influence: 6.6] [Reference Citation Analysis]
330 Kojima F, Kapoor M, Kawai S, Crofford LJ. New insights into eicosanoid biosynthetic pathways: implications for arthritis. Expert Review of Clinical Immunology 2014;2:277-91. [DOI: 10.1586/1744666x.2.2.277] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
331 Araujo P, Lucena E, Yang Y, Ceemala B, Mengesha Z, Holen E. The impact of exogenous ω-6 and ω-3 polyunsaturated fatty acids on the induced production of pro- and anti-inflammatory prostaglandins and leukotrienes in Atlantic salmon head kidney cells using a full factorial design and LC–MS/MS. Journal of Chromatography B 2014;964:164-71. [DOI: 10.1016/j.jchromb.2014.01.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
332 Kotlyarov S, Kotlyarova A. Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease. Int J Mol Sci 2021;22:12803. [PMID: 34884621 DOI: 10.3390/ijms222312803] [Reference Citation Analysis]
333 Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621. [PMID: 20192811 DOI: 10.1146/annurev-immunol-030409-101225.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
334 Serhan CN. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins: . Current Opinion in Clinical Nutrition and Metabolic Care 2005;8:115-21. [DOI: 10.1097/00075197-200503000-00003] [Cited by in Crossref: 166] [Cited by in F6Publishing: 129] [Article Influence: 9.8] [Reference Citation Analysis]
335 Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007;28:176-183. [PMID: 17337246 DOI: 10.1016/j.it.2007.02.007] [Cited by in Crossref: 241] [Cited by in F6Publishing: 224] [Article Influence: 16.1] [Reference Citation Analysis]
336 Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW. Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 2010;161:707-20. [PMID: 20880407 DOI: 10.1111/j.1476-5381.2010.00909.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 9.5] [Reference Citation Analysis]
337 Menarim BC, Gillis KH, Oliver A, Ngo Y, Werre SR, Barrett SH, Rodgerson DH, Dahlgren LA. Macrophage Activation in the Synovium of Healthy and Osteoarthritic Equine Joints. Front Vet Sci. 2020;7:568756. [PMID: 33324696 DOI: 10.3389/fvets.2020.568756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
338 Kang J, Lee G, Jeung E, Yang M. Trans -10, cis -12-conjugated linoleic acid increases phagocytosis of porcine peripheral blood polymorphonuclear cells in vitro. Br J Nutr 2007;97:117-25. [DOI: 10.1017/s0007114507280584] [Cited by in Crossref: 23] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
339 van der Hoeven D, Wan TC, Auchampach JA. Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils. Mol Pharmacol 2008;74:685-96. [PMID: 18583455 DOI: 10.1124/mol.108.048066] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 4.0] [Reference Citation Analysis]
340 Motwani MP, Newson J, Kwong S, Richard-Loendt A, Colas R, Dalli J, Gilroy DW. Prolonged immune alteration following resolution of acute inflammation in humans. PLoS One 2017;12:e0186964. [PMID: 29073216 DOI: 10.1371/journal.pone.0186964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
341 Markworth JF, Brown LA, Lim E, Floyd C, Larouche J, Castor-Macias JA, Sugg KB, Sarver DC, Macpherson PC, Davis C, Aguilar CA, Maddipati KR, Brooks SV. Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells. JCI Insight 2020;5:137713. [PMID: 32750044 DOI: 10.1172/jci.insight.137713] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
342 Pashover-Schallinger E, Aswad M, Schif-Zuck S, Shapiro H, Singer P, Ariel A. The atypical chemokine receptor D6 controls macrophage efferocytosis and cytokine secretion during the resolution of inflammation. FASEB J 2012;26:3891-900. [PMID: 22651933 DOI: 10.1096/fj.11-194894] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
343 Fernandes SM, Watanabe M, Vattimo MFF. Inflammation: improving understanding to prevent or ameliorate kidney diseases. J Venom Anim Toxins Incl Trop Dis 2021;27:e20200162. [PMID: 34712277 DOI: 10.1590/1678-9199-JVATITD-2020-0162] [Reference Citation Analysis]
344 Teixeira RA, Mimura KK, Araujo LP, Greco KV, Oliani SM. The essential role of annexin A1 mimetic peptide in the skin allograft survival. J Tissue Eng Regen Med 2016;10:E44-53. [PMID: 23897745 DOI: 10.1002/term.1773] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
345 Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014;40:315-327. [PMID: 24656045 DOI: 10.1016/j.immuni.2014.02.009] [Cited by in Crossref: 436] [Cited by in F6Publishing: 429] [Article Influence: 54.5] [Reference Citation Analysis]
346 Koeberle A, Laufer SA, Werz O. Design and Development of Microsomal Prostaglandin E 2 Synthase-1 Inhibitors: Challenges and Future Directions. J Med Chem 2016;59:5970-86. [DOI: 10.1021/acs.jmedchem.5b01750] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
347 Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349-361. [PMID: 18437155 DOI: 10.1038/nri2294] [Cited by in Crossref: 1820] [Cited by in F6Publishing: 1699] [Article Influence: 130.0] [Reference Citation Analysis]
348 Devitt A, Griffiths HR, Milic I. Communicating with the dead: lipids, lipid mediators and extracellular vesicles. Biochem Soc Trans 2018;46:631-9. [PMID: 29743274 DOI: 10.1042/BST20160477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
349 Rong S, Cao Q, Liu M, Seo J, Jia L, Boudyguina E, Gebre AK, Colvin PL, Smith TL, Murphy RC, Mishra N, Parks JS. Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis. J Lipid Res 2012;53:686-95. [PMID: 22279185 DOI: 10.1194/jlr.M022723] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
350 Hellmann J, Tang Y, Zhang MJ, Hai T, Bhatnagar A, Srivastava S, Spite M. Atf3 negatively regulates Ptgs2/Cox2 expression during acute inflammation. Prostaglandins Other Lipid Mediat 2015;116-117:49-56. [PMID: 25619459 DOI: 10.1016/j.prostaglandins.2015.01.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
351 Wu S, Liao P, Yin P, Zhang Y, Dong L. Inverse temporal changes of lipoxin A4 and leukotrienes in children with Henoch–Schönlein purpura. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009;80:177-83. [DOI: 10.1016/j.plefa.2009.01.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
352 Cordaro M, Cuzzocrea S, Crupi R. An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events. Antioxidants (Basel) 2020;9:E216. [PMID: 32150935 DOI: 10.3390/antiox9030216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
353 Lütfioğlu M, Aydoğdu A, Sakallioğlu EE, Alaçam H, Pamuk F. Gingival crevicular fluid interleukin-8 and lipoxin A4 levels of smokers and nonsmokers with different periodontal status: a cross-sectional study. J Periodontal Res 2016;51:471-80. [PMID: 26446985 DOI: 10.1111/jre.12324] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
354 Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J. 2006;1:420-439. [PMID: 16892270 DOI: 10.1002/biot.200600012] [Cited by in Crossref: 361] [Cited by in F6Publishing: 317] [Article Influence: 22.6] [Reference Citation Analysis]
355 Sommakia S, Baker OJ. Regulation of inflammation by lipid mediators in oral diseases. Oral Dis 2017;23:576-97. [PMID: 27426637 DOI: 10.1111/odi.12544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
356 Voiriot G, Philippot Q, Elabbadi A, Elbim C, Chalumeau M, Fartoukh M. Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients. J Clin Med 2019;8:E786. [PMID: 31163625 DOI: 10.3390/jcm8060786] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 17.3] [Reference Citation Analysis]
357 Havixbeck JJ, Rieger AM, Churchill LJ, Barreda DR. Neutrophils exert protection in early Aeromonas veronii infections through the clearance of both bacteria and dying macrophages. Fish Shellfish Immunol 2017;63:18-30. [PMID: 28167251 DOI: 10.1016/j.fsi.2017.02.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
358 Toda M, Shao Z, Yamaguchi KD, Takagi T, D'Alessandro-Gabazza CN, Taguchi O, Salamon H, Leung LL, Gabazza EC, Morser J. Differential gene expression in thrombomodulin (TM; CD141)(+) and TM(-) dendritic cell subsets. PLoS One 2013;8:e72392. [PMID: 24009678 DOI: 10.1371/journal.pone.0072392] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
359 Gavins FN, Hughes EL, Buss NA, Holloway PM, Getting SJ, Buckingham JC. Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system. FASEB J 2012;26:4977-89. [PMID: 22964301 DOI: 10.1096/fj.12-205971] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
360 Hasturk H, Kantarci A, Van Dyke TE. Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol 2012;15:160-76. [PMID: 22142963 DOI: 10.1159/000329678] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
361 Musso G, Gambino R, Cassader M, Paschetta E, Sircana A. Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution. Trends in Pharmacological Sciences 2018;39:387-401. [DOI: 10.1016/j.tips.2018.01.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
362 Cooper PR, Palmer LJ, Chapple IL. Neutrophil extracellular traps as a new paradigm in innate immunity: friend or foe? Periodontol 2000 2013;63:165-97. [PMID: 23931060 DOI: 10.1111/prd.12025] [Cited by in Crossref: 98] [Cited by in F6Publishing: 97] [Article Influence: 14.0] [Reference Citation Analysis]
363 El Kebir D, Filep JG. Modulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins. Front Immunol 2013;4:60. [PMID: 23508943 DOI: 10.3389/fimmu.2013.00060] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 6.3] [Reference Citation Analysis]
364 Sansbury BE, Spite M. Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology. Circ Res 2016;119:113-30. [PMID: 27340271 DOI: 10.1161/CIRCRESAHA.116.307308] [Cited by in Crossref: 91] [Cited by in F6Publishing: 48] [Article Influence: 18.2] [Reference Citation Analysis]
365 Yamamoto T, Miyata J, Arita M, Fukunaga K, Kawana A. Current state and future prospect of the therapeutic strategy targeting cysteinyl leukotriene metabolism in asthma. Respir Investig 2019;57:534-43. [PMID: 31591069 DOI: 10.1016/j.resinv.2019.08.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
366 Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP. Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci U S A 2002;99:3902-7. [PMID: 11891303 DOI: 10.1073/pnas.052533799] [Cited by in Crossref: 209] [Cited by in F6Publishing: 197] [Article Influence: 10.5] [Reference Citation Analysis]
367 Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000 2013;63:149-64. [PMID: 23931059 DOI: 10.1111/prd.12034] [Cited by in Crossref: 169] [Cited by in F6Publishing: 153] [Article Influence: 24.1] [Reference Citation Analysis]
368 Zhu X, Peng X, Lin J, Zhang Y, He H, Zhao G. Lipoxin A4 activates ALX/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis. Int Immunopharmacol 2021;96:107785. [PMID: 34162149 DOI: 10.1016/j.intimp.2021.107785] [Reference Citation Analysis]
369 Sitkovsky MV. Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem Pharmacol 2003;65:493-501. [PMID: 12566076 DOI: 10.1016/s0006-2952(02)01548-4] [Cited by in Crossref: 114] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
370 Krishnamoorthy N, Abdulnour RE, Walker KH, Engstrom BD, Levy BD. Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases. Physiol Rev 2018;98:1335-70. [PMID: 29717929 DOI: 10.1152/physrev.00026.2017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
371 Kawano Y, Fukui C, Shinohara M, Wakahashi K, Ishii S, Suzuki T, Sato M, Asada N, Kawano H, Minagawa K, Sada A, Furuyashiki T, Uematsu S, Akira S, Uede T, Narumiya S, Matsui T, Katayama Y. G-CSF-induced sympathetic tone provokes fever and primes antimobilizing functions of neutrophils via PGE2. Blood 2017;129:587-97. [PMID: 27827823 DOI: 10.1182/blood-2016-07-725754] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
372 Haak VM, Huang S, Panigrahy D. Debris-stimulated tumor growth: a Pandora's box? Cancer Metastasis Rev 2021;40:791-801. [PMID: 34665387 DOI: 10.1007/s10555-021-09998-8] [Reference Citation Analysis]
373 Marruchella G, Giacominelli-Stuffler R, Baffoni M, Maccarrone M. 5-lipoxygenase and cyclooxygenase-2 in porcine parasitic bronchopneumonia: immunohistochemical and biochemical investigations. J Comp Pathol 2010;142:139-46. [PMID: 19906385 DOI: 10.1016/j.jcpa.2009.09.004] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
374 Kaushal N, Kudva AK, Patterson AD, Chiaro C, Kennett MJ, Desai D, Amin S, Carlson BA, Cantorna MT, Prabhu KS. Crucial role of macrophage selenoproteins in experimental colitis. J Immunol. 2014;193:3683-3692. [PMID: 25187657 DOI: 10.4049/jimmunol.1400347] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
375 Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 2010;177:1576-91. [PMID: 20813960 DOI: 10.2353/ajpath.2010.100322] [Cited by in Crossref: 289] [Cited by in F6Publishing: 266] [Article Influence: 24.1] [Reference Citation Analysis]
376 Soory M. Oxidative stress induced mechanisms in the progression of periodontal diseases and cancer: a common approach to redox homeostasis? Cancers (Basel) 2010;2:670-92. [PMID: 24281088 DOI: 10.3390/cancers2020670] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
377 Muka T, Kiefte-de Jong JC, Hofman A, Dehghan A, Rivadeneira F, Franco OH. Polyunsaturated fatty acids and serum C-reactive protein: the Rotterdam study. Am J Epidemiol 2015;181:846-56. [PMID: 25899092 DOI: 10.1093/aje/kwv021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
378 Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med. 2001;7:1291-1297. [PMID: 11726968 DOI: 10.1038/nm1201-1291] [Cited by in Crossref: 563] [Cited by in F6Publishing: 528] [Article Influence: 28.2] [Reference Citation Analysis]
379 Nicolaou A, Masoodi M, Gledhill K, Haylett AK, Thody AJ, Tobin DJ, Rhodes LE. The eicosanoid response to high dose UVR exposure of individuals prone and resistant to sunburn. Photochem Photobiol Sci 2012;11:371-80. [PMID: 22173231 DOI: 10.1039/c1pp05272a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
380 Fierro IM. Angiogenesis and lipoxins. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005;73:271-5. [DOI: 10.1016/j.plefa.2005.05.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
381 Heffron SP, Weinstock A, Scolaro B, Chen S, Sansbury BE, Marecki G, Rolling CC, El Bannoudi H, Barrett T, Canary JW, Spite M, Berger JS, Fisher EA. Platelet-conditioned media induces an anti-inflammatory macrophage phenotype through EP4. J Thromb Haemost 2021;19:562-73. [PMID: 33171016 DOI: 10.1111/jth.15172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
382 Levy BD, Zhang QY, Bonnans C, Primo V, Reilly JJ, Perkins DL, Liang Y, Amin Arnaout M, Nikolic B, Serhan CN. The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection. Prostaglandins Leukot Essent Fatty Acids 2011;84:43-50. [PMID: 20869861 DOI: 10.1016/j.plefa.2010.09.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
383 Prüss H, Rosche B, Sullivan AB, Brommer B, Wengert O, Gronert K, Schwab JM. Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial. PLoS One 2013;8:e55859. [PMID: 23409068 DOI: 10.1371/journal.pone.0055859] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
384 Filep JG. Resolution pathways in inflammation: the devil in the adipose tissues and in the details. Focus on "Diversity of lipid mediators in human adipose tissue depots". Am J Physiol Cell Physiol 2013;304:C1127-8. [PMID: 23467298 DOI: 10.1152/ajpcell.00063.2013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
385 Capra V, Bäck M, Barbieri SS, Camera M, Tremoli E, Rovati GE. Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke: EICOSANOIDS AND THEIR DRUGS IN CVDS. Med Res Rev 2013;33:364-438. [DOI: 10.1002/med.21251] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
386 Dalli J, Gomez EA, Jouvene CC. Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease. Biomolecules 2022;12:353. [DOI: 10.3390/biom12030353] [Reference Citation Analysis]
387 Ejima K, Layne MD, Carvajal IM, Kritek PA, Baron RM, Chen Y, Vom Saal J, Levy BD, Yet S, Perrella MA. Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death. FASEB j 2003;17:1325-7. [DOI: 10.1096/fj.02-1078fje] [Cited by in Crossref: 100] [Cited by in F6Publishing: 97] [Article Influence: 5.3] [Reference Citation Analysis]
388 Trojan E, Bryniarska N, Leśkiewicz M, Regulska M, Chamera K, Szuster-Głuszczak M, Leopoldo M, Lacivita E, Basta-Kaim A. The Contribution of Formyl Peptide Receptor Dysfunction to the Course of Neuroinflammation: A Potential Role in the Brain Pathology. Curr Neuropharmacol 2020;18:229-49. [PMID: 31629396 DOI: 10.2174/1570159X17666191019170244] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
389 Behar SM, Martin CJ, Booty MG, Nishimura T, Zhao X, Gan HX, Divangahi M, Remold HG. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol 2011;4:279-87. [PMID: 21307848 DOI: 10.1038/mi.2011.3] [Cited by in Crossref: 228] [Cited by in F6Publishing: 225] [Article Influence: 20.7] [Reference Citation Analysis]
390 Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD, Serhan CN. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol. 2006;7:1209-1216. [PMID: 17013391 DOI: 10.1038/ni1392] [Cited by in Crossref: 234] [Cited by in F6Publishing: 231] [Article Influence: 14.6] [Reference Citation Analysis]
391 Kotlyarov S, Kotlyarova A. Molecular Mechanisms of Lipid Metabolism Disorders in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease. Int J Mol Sci 2021;22:7634. [PMID: 34299266 DOI: 10.3390/ijms22147634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
392 Cash JL, Bena S, Headland SE, McArthur S, Brancaleone V, Perretti M. Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23. EMBO Rep 2013;14:999-1007. [PMID: 23999103 DOI: 10.1038/embor.2013.138] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
393 Martin TD, Chan SS, Hart AR. Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature. Dig Dis Sci. 2015;60:1396-1405. [PMID: 25407806 DOI: 10.1007/s10620-014-3437-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
394 Vickery TW, Armstrong M, Kofonow JM, Robertson CE, Kroehl ME, Reisdorph NA, Ramakrishnan VR, Frank DN. Altered tissue specialized pro-resolving mediators in chronic rhinosinusitis. Prostaglandins Leukot Essent Fatty Acids 2021;164:102218. [PMID: 33338738 DOI: 10.1016/j.plefa.2020.102218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
395 Serhan CN. Resolvins and protectins: novel lipid mediators in anti-inflammation and resolution. Scandinavian Journal of Food and Nutrition 2016;50:68-78. [DOI: 10.1080/17482970601066298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
396 Fredenburgh LE, Velandia MM, Ma J, Olszak T, Cernadas M, Englert JA, Chung SW, Liu X, Begay C, Padera RF, Blumberg RS, Walsh SR, Baron RM, Perrella MA. Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis. J Immunol 2011;187:5255-67. [PMID: 21967897 DOI: 10.4049/jimmunol.1101186] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
397 Benson M. Pathophysiological effects of glucocorticoids on nasal polyps: an update. Curr Opin Allergy Clin Immunol 2005;5:31-5. [PMID: 15643341 DOI: 10.1097/00130832-200502000-00007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
398 Bergqvist F, Carr AJ, Wheway K, Watkins B, Oppermann U, Jakobsson PJ, Dakin SG. Divergent roles of prostacyclin and PGE2 in human tendinopathy. Arthritis Res Ther 2019;21:74. [PMID: 30867043 DOI: 10.1186/s13075-019-1855-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
399 Landén NX, Li D, Ståhle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci 2016;73:3861-85. [PMID: 27180275 DOI: 10.1007/s00018-016-2268-0] [Cited by in Crossref: 397] [Cited by in F6Publishing: 344] [Article Influence: 66.2] [Reference Citation Analysis]
400 Clària J, Planagumà A. Liver: The formation and actions of aspirin-triggered lipoxins. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005;73:277-82. [DOI: 10.1016/j.plefa.2005.05.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
401 de Los Reyes Jiménez M, Lechner A, Alessandrini F, Bohnacker S, Schindela S, Trompette A, Haimerl P, Thomas D, Henkel F, Mourão A, Geerlof A, da Costa CP, Chaker AM, Brüne B, Nüsing R, Jakobsson PJ, Nockher WA, Feige MJ, Haslbeck M, Ohnmacht C, Marsland BJ, Voehringer D, Harris NL, Schmidt-Weber CB, Esser-von Bieren J. An anti-inflammatory eicosanoid switch mediates the suppression of type-2 inflammation by helminth larval products. Sci Transl Med 2020;12:eaay0605. [PMID: 32321863 DOI: 10.1126/scitranslmed.aay0605] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
402 Nesman JI, Gangestad Primdahl K, Tungen JE, Palmas F, Dalli J, Hansen TV. Synthesis, Structural Confirmation, and Biosynthesis of 22-OH-PD1n-3 DPA. Molecules 2019;24:E3228. [PMID: 31491851 DOI: 10.3390/molecules24183228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
403 Bürgin-Maunder CS, Brooks PR, Russell FD. Omega-3 fatty acids modulate Weibel-Palade body degranulation and actin cytoskeleton rearrangement in PMA-stimulated human umbilical vein endothelial cells. Mar Drugs 2013;11:4435-50. [PMID: 24217286 DOI: 10.3390/md11114435] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
404 Chen QF, Kuang XD, Yuan QF, Hao H, Zhang T, Huang YH, Zhou XY. Lipoxin A4 attenuates LPS-induced acute lung injury via activation of the ACE2-Ang-(1-7)-Mas axis. Innate Immun 2018;24:285-96. [PMID: 29969931 DOI: 10.1177/1753425918785008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
405 Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 2013;339:166-72. [PMID: 23307734 DOI: 10.1126/science.1230720] [Cited by in Crossref: 653] [Cited by in F6Publishing: 606] [Article Influence: 72.6] [Reference Citation Analysis]
406 Connor AJ, Chen LC, Joseph LB, Laskin JD, Laskin DL. Distinct responses of lung and liver macrophages to acute endotoxemia: role of toll-like receptor 4. Exp Mol Pathol 2013;94:216-27. [PMID: 23000425 DOI: 10.1016/j.yexmp.2012.09.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
407 Serhan CN. Clues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases? Expert Opinion on Therapeutic Targets 2005;8:643-52. [DOI: 10.1517/14728222.8.6.643] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
408 Anstead GM, Zhang Q, Melby PC. Malnutrition promotes prostaglandin over leukotriene production and dysregulates eicosanoid-cytokine crosstalk in activated resident macrophages. Prostaglandins Leukot Essent Fatty Acids 2009;81:41-51. [PMID: 19541468 DOI: 10.1016/j.plefa.2009.04.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
409 Qu Q, Xuan W, Fan GH. Roles of resolvins in the resolution of acute inflammation. Cell Biol Int 2015;39:3-22. [PMID: 25052386 DOI: 10.1002/cbin.10345] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
410 Bouriche H, Miles E, Selloum L, Calder P. Effect of Cleome arabica leaf extract, rutin and quercetin on soybean lipoxygenase activity and on generation of inflammatory eicosanoids by human neutrophils. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005;72:195-201. [DOI: 10.1016/j.plefa.2004.10.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
411 Varga T, Czimmerer Z, Nagy L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta. 2011;1812:1007-1022. [PMID: 21382489 DOI: 10.1016/j.bbadis.2011.02.014] [Cited by in Crossref: 458] [Cited by in F6Publishing: 424] [Article Influence: 41.6] [Reference Citation Analysis]
412 Bauer E, Metzler-zebeli BU, Verstegen MWA, Mosenthin R. Intestinal gene expression in pigs: effects of reduced feed intake during weaning and potential impact of dietary components. Nutr Res Rev 2011;24:155-75. [DOI: 10.1017/s0954422411000047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
413 Calder PC. n-3 fatty acids, inflammation, and immunity--relevance to postsurgical and critically ill patients. Lipids 2004;39:1147-61. [PMID: 15736910 DOI: 10.1007/s11745-004-1342-z] [Cited by in Crossref: 114] [Cited by in F6Publishing: 89] [Article Influence: 6.7] [Reference Citation Analysis]
414 Hansen TV, Vik A, Serhan CN. The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes. Front Pharmacol 2018;9:1582. [PMID: 30705632 DOI: 10.3389/fphar.2018.01582] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
415 White PJ, Marette A. Potential role of omega‐3‐derived resolution mediators in metabolic inflammation. Immunol Cell Biol 2014;92:324-30. [DOI: 10.1038/icb.2013.112] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
416 Maderna P, Godson C. Lipoxins: resolutionary road. Br J Pharmacol 2009;158:947-59. [PMID: 19785661 DOI: 10.1111/j.1476-5381.2009.00386.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 136] [Article Influence: 11.5] [Reference Citation Analysis]
417 Bogie JF, Haidar M, Kooij G, Hendriks JJ. Fatty acid metabolism in the progression and resolution of CNS disorders. Advanced Drug Delivery Reviews 2020;159:198-213. [DOI: 10.1016/j.addr.2020.01.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
418 de Wit NM, Mol K, Rodríguez-Lorenzo S, de Vries HE, Kooij G. The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease. Front Immunol 2020;11:620348. [PMID: 33633739 DOI: 10.3389/fimmu.2020.620348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
419 Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, Riley NA, Caldicott A, Martinez-Losa M, Walker TR, Duffin R, Gray M, Crescenzi E, Martin MC, Brady HJ, Savill JS, Dransfield I, Haslett C. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 2006;12:1056-64. [PMID: 16951685 DOI: 10.1038/nm1468] [Cited by in Crossref: 345] [Cited by in F6Publishing: 345] [Article Influence: 21.6] [Reference Citation Analysis]
420 Chatterjee A, Komshian S, Sansbury BE, Wu B, Mottola G, Chen M, Spite M, Conte MS. Biosynthesis of proresolving lipid mediators by vascular cells and tissues. FASEB J 2017;31:3393-402. [PMID: 28442547 DOI: 10.1096/fj.201700082R] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
421 Martinez RM, Fattori V, Saito P, Pinto IC, Rodrigues CCA, Melo CPB, Bussmann AJC, Staurengo-Ferrari L, Bezerra JR, Vignoli JA, Baracat MM, Georgetti SR, Verri WA Jr, Casagrande R. The Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin Against Ultraviolet B Radiation. Molecules 2020;25:E2953. [PMID: 32604968 DOI: 10.3390/molecules25122953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
422 Sala A, Profita M, Siena L, Henson PM, Murphy RC, Paternò A, Bonanno A, Riccobono L, Mirabella A, Bonsignore G, Vignola AM. Il-4-induced lipid mediators class switching in human normal mononuclear phagocytes. Adv Exp Med Biol 2003;525:15-8. [PMID: 12751729 DOI: 10.1007/978-1-4419-9194-2_4] [Reference Citation Analysis]
423 Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001;414:916-920. [PMID: 11780065 DOI: 10.1038/414916a] [Cited by in Crossref: 872] [Cited by in F6Publishing: 843] [Article Influence: 43.6] [Reference Citation Analysis]
424 Buchman TG. The community of the self. Nature 2002;420:246-51. [DOI: 10.1038/nature01260] [Cited by in Crossref: 139] [Cited by in F6Publishing: 130] [Article Influence: 7.0] [Reference Citation Analysis]
425 Thomas CJ, Schroder K. Pattern recognition receptor function in neutrophils. Trends in Immunology 2013;34:317-28. [DOI: 10.1016/j.it.2013.02.008] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 11.1] [Reference Citation Analysis]
426 Duvall MG, Bruggemann TR, Levy BD. Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation. Mol Aspects Med 2017;58:44-56. [PMID: 28455109 DOI: 10.1016/j.mam.2017.04.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
427 Hartling I, Cremonesi A, Osuna E, Lou PH, Lucchinetti E, Zaugg M, Hersberger M. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS. Clin Chem Lab Med 2021. [PMID: 34243224 DOI: 10.1515/cclm-2021-0644] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
428 Rostoker R, Yaseen H, Schif-zuck S, Lichtenstein RG, Rabinovich GA, Ariel A. Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype. Prostaglandins & Other Lipid Mediators 2013;107:85-94. [DOI: 10.1016/j.prostaglandins.2013.08.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
429 Awji EG, Chand H, Bruse S, Smith KR, Colby JK, Mebratu Y, Levy BD, Tesfaigzi Y. Wood smoke enhances cigarette smoke-induced inflammation by inducing the aryl hydrocarbon receptor repressor in airway epithelial cells. Am J Respir Cell Mol Biol 2015;52:377-86. [PMID: 25137396 DOI: 10.1165/rcmb.2014-0142OC] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
430 Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O’Neill LA, Perretti M, Rossi AG, Wallace JL. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007;21:325-332. [PMID: 17267386 DOI: 10.1096/fj.06-7227rev] [Cited by in Crossref: 719] [Cited by in F6Publishing: 693] [Article Influence: 47.9] [Reference Citation Analysis]
431 Horta AL, Williams T, Han B, Ma Y, Menezes APJ, Tu V, Talvani A, Weiss LM, Huang H. Resolvin D1 Administration Is Beneficial in Trypanosoma cruzi Infection. Infect Immun 2020;88:e00052-20. [PMID: 32152197 DOI: 10.1128/IAI.00052-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
432 Kowal-Bielecka O, Kowal K, Distler O, Rojewska J, Bodzenta-Lukaszyk A, Michel BA, Gay RE, Gay S, Sierakowski S. Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators. Arthritis Rheum 2005;52:3783-91. [PMID: 16320329 DOI: 10.1002/art.21432] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
433 Chu FF, Esworthy RS, Doroshow JH. Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer. Free Radic Biol Med. 2004;36:1481-1495. [PMID: 15182851 DOI: 10.1016/j.freeradbiomed.2004.04.010] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 6.6] [Reference Citation Analysis]
434 Gilroy DW. The endogenous control of acute inflammation – from onset to resolution. Drug Discovery Today: Therapeutic Strategies 2004;1:313-9. [DOI: 10.1016/j.ddstr.2004.11.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
435 Jordan PM, Werz O. Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections. FEBS J 2021. [PMID: 34741578 DOI: 10.1111/febs.16266] [Reference Citation Analysis]
436 Kaur S, Lyte P, Garay M, Liebel F, Sun Y, Liu J, Southall MD. Galvanic zinc–copper microparticles produce electrical stimulation that reduces the inflammatory and immune responses in skin. Arch Dermatol Res 2011;303:551-62. [DOI: 10.1007/s00403-011-1145-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
437 Gattorno M, Martini A. Inflammation and Its Mediators. Textbook of Pediatric Rheumatology. Elsevier; 2016. pp. 14-32.e2. [DOI: 10.1016/b978-0-323-24145-8.00003-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
438 Chiang N, Bermudez EA, Ridker PM, Hurwitz S, Serhan CN. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc Natl Acad Sci U S A 2004;101:15178-83. [PMID: 15471991 DOI: 10.1073/pnas.0405445101] [Cited by in Crossref: 175] [Cited by in F6Publishing: 160] [Article Influence: 9.7] [Reference Citation Analysis]
439 Sima C, Paster B, Van Dyke TE. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes. Crit Rev Immunol 2018;38:343-65. [PMID: 30806214 DOI: 10.1615/CritRevImmunol.2018026750] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
440 Konya V, Mjösberg J. Lipid mediators as regulators of human ILC2 function in allergic diseases. Immunol Lett 2016;179:36-42. [PMID: 27396531 DOI: 10.1016/j.imlet.2016.07.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
441 Boer J, Jemec GB. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin Exp Dermatol 2010;35:36-40. [PMID: 19549239 DOI: 10.1111/j.1365-2230.2009.03377.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
442 Miles EA, Childs CE, Calder PC. Long-Chain Polyunsaturated Fatty Acids (LCPUFAs) and the Developing Immune System: A Narrative Review. Nutrients 2021;13:247. [PMID: 33467123 DOI: 10.3390/nu13010247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
443 Anderson P, Delgado M. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders. J Cell Mol Med 2008;12:1830-47. [PMID: 18554314 DOI: 10.1111/j.1582-4934.2008.00387.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
444 Surowiec I, Gouveia-Figueira S, Orikiiriza J, Lindquist E, Bonde M, Magambo J, Muhinda C, Bergström S, Normark J, Trygg J. The oxylipin and endocannabidome responses in acute phase Plasmodium falciparum malaria in children. Malar J 2017;16:358. [PMID: 28886714 DOI: 10.1186/s12936-017-2001-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
445 Headland SE, Norling LV. The resolution of inflammation: Principles and challenges. Semin Immunol 2015;27:149-60. [PMID: 25911383 DOI: 10.1016/j.smim.2015.03.014] [Cited by in Crossref: 191] [Cited by in F6Publishing: 175] [Article Influence: 27.3] [Reference Citation Analysis]
446 Yamada T, Tani Y, Nakanishi H, Taguchi R, Arita M, Arai H. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J 2011;25:561-8. [PMID: 20959515 DOI: 10.1096/fj.10-170027] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 8.2] [Reference Citation Analysis]
447 El Kebir D, József L, Filep JG. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation. J Leukoc Biol 2008;84:600-6. [PMID: 18495783 DOI: 10.1189/jlb.1107765] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
448 Palmer CD, Mancuso CJ, Weiss JP, Serhan CN, Guinan EC, Levy O. 17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli. J Leukoc Biol 2011;90:459-70. [PMID: 21653234 DOI: 10.1189/jlb.0311145] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
449 Calder PC. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie. 2009;91:791-795. [PMID: 19455748 DOI: 10.1016/j.biochi.2009.01.008] [Cited by in Crossref: 448] [Cited by in F6Publishing: 391] [Article Influence: 34.5] [Reference Citation Analysis]
450 Gilroy DW, Bishop-Bailey D. Lipid mediators in immune regulation and resolution. Br J Pharmacol 2019;176:1009-23. [PMID: 30674066 DOI: 10.1111/bph.14587] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
451 Wu SH, Yin PL, Zhang YM, Tao HX. Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree. Pediatr Pulmonol 2010;45:333-40. [PMID: 20232472 DOI: 10.1002/ppul.21186] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
452 Huwiler A, Pfeilschifter J. Lipids as targets for novel anti-inflammatory therapies. Pharmacol Ther 2009;124:96-112. [PMID: 19576246 DOI: 10.1016/j.pharmthera.2009.06.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
453 Baker LM, Baker PR, Golin-Bisello F, Schopfer FJ, Fink M, Woodcock SR, Branchaud BP, Radi R, Freeman BA. Nitro-fatty acid reaction with glutathione and cysteine. Kinetic analysis of thiol alkylation by a Michael addition reaction. J Biol Chem 2007;282:31085-93. [PMID: 17720974 DOI: 10.1074/jbc.M704085200] [Cited by in F6Publishing: 77] [Reference Citation Analysis]
454 De Lorgeril ME. Essential Polyunsaturated Fatty Acids, Inflammation, Atherosclerosis and Cardiovascular Diseases. In: Harris RE, Bittman R, Dasgupta D, Engelhardt H, Flohe L, Herrmann H, Holzenburg A, Nasheuer H, Rottem S, Wyss M, Zwickl P, editors. Inflammation in the Pathogenesis of Chronic Diseases. Dordrecht: Springer Netherlands; 2007. pp. 283-97. [DOI: 10.1007/1-4020-5688-5_13] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
455 Starosta V, Pazdrak K, Boldogh I, Svider T, Kurosky A. Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytes. J Immunol 2008;181:8688-99. [PMID: 19050289 DOI: 10.4049/jimmunol.181.12.8688] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
456 Schulte F, Asbeutah AA, Benotti PN, Wood GC, Still C, Bistrian BR, Hardt M, Welty FK. The relationship between specialized pro-resolving lipid mediators, morbid obesity and weight loss after bariatric surgery. Sci Rep 2020;10:20128. [PMID: 33208757 DOI: 10.1038/s41598-020-75353-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
457 Rothlin CV, Leighton JA, Ghosh S. Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer. Inflamm Bowel Dis. 2014;20:1472-1480. [PMID: 24846720 DOI: 10.1097/mib.0000000000000050] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
458 Kutzner L, Rund KM, Ostermann AI, Hartung NM, Galano JM, Balas L, Durand T, Balzer MS, David S, Schebb NH. Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples. Front Pharmacol 2019;10:169. [PMID: 30899221 DOI: 10.3389/fphar.2019.00169] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
459 Arnardottir H, Orr SK, Dalli J, Serhan CN. Human milk proresolving mediators stimulate resolution of acute inflammation. Mucosal Immunol 2016;9:757-66. [PMID: 26462421 DOI: 10.1038/mi.2015.99] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 10.4] [Reference Citation Analysis]
460 Piotrowska-tomala K, Bah M, Jankowska K, Lukasik K, Warmowski P, Galvao A, Skarzynski D. Lipopolysaccharides, cytokines, and nitric oxide affect secretion of prostaglandins and leukotrienes by bovine mammary gland during experimentally induced mastitis in vivo and in vitro. Domestic Animal Endocrinology 2015;52:90-9. [DOI: 10.1016/j.domaniend.2015.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
461 Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res. 2008;47:147-155. [PMID: 18198131 DOI: 10.1016/j.plipres.2007.12.004] [Cited by in Crossref: 693] [Cited by in F6Publishing: 606] [Article Influence: 46.2] [Reference Citation Analysis]
462 Plante H, Picard S, Mancini J, Borgeat P. 5-Lipoxygenase-activating protein homodimer in human neutrophils: evidence for a role in leukotriene biosynthesis. Biochem J 2006;393:211-8. [PMID: 16144515 DOI: 10.1042/BJ20050669] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
463 Serhan CN. The resolution of inflammation: the devil in the flask and in the details. FASEB J 2011;25:1441-8. [PMID: 21532053 DOI: 10.1096/fj.11-0502ufm] [Cited by in Crossref: 126] [Cited by in F6Publishing: 121] [Article Influence: 11.5] [Reference Citation Analysis]
464 Jones HR, Robb CT, Perretti M, Rossi AG. The role of neutrophils in inflammation resolution. Seminars in Immunology 2016;28:137-45. [DOI: 10.1016/j.smim.2016.03.007] [Cited by in Crossref: 128] [Cited by in F6Publishing: 120] [Article Influence: 21.3] [Reference Citation Analysis]
465 Shearer GC, Walker RE. An overview of the biologic effects of omega-6 oxylipins in humans. Prostaglandins Leukot Essent Fatty Acids 2018;137:26-38. [PMID: 30293594 DOI: 10.1016/j.plefa.2018.06.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
466 Kurihara T, Jones CN, Yu YM, Fischman AJ, Watada S, Tompkins RG, Fagan SP, Irimia D. Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J 2013;27:2270-81. [PMID: 23430978 DOI: 10.1096/fj.12-219519] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
467 Gomez G, Sitkovsky MV. Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 2003;102:4472-8. [PMID: 12947007 DOI: 10.1182/blood-2002-11-3624] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 4.1] [Reference Citation Analysis]
468 Gao Y, Wang N, Li RH, Xiao YZ. The Role of Autophagy and the Chemokine (C-X-C Motif) Ligand 16 During Acute Lung Injury in Mice. Med Sci Monit 2018;24:2404-12. [PMID: 29677174 DOI: 10.12659/msm.906016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
469 Yang X, Chen WY, Gong Y, DI LQ, Duan JA, Zhou J, Ma HY. A target lipidomics approach to investigate the acute inflammatory irritation induced by indolealkylamines from Chansu water fraction in rats. Chin J Nat Med 2021;19:856-67. [PMID: 34844724 DOI: 10.1016/S1875-5364(21)60117-6] [Reference Citation Analysis]
470 Bilsborough J, Fiorino MF, Henkle BW. Select animal models of colitis and their value in predicting clinical efficacy of biological therapies in ulcerative colitis. Expert Opin Drug Discov 2021;16:567-77. [PMID: 33245673 DOI: 10.1080/17460441.2021.1851185] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
471 Urbach V, Higgins G, Buchanan P, Ringholz F. The role of Lipoxin A4 in Cystic Fibrosis Lung Disease. Comput Struct Biotechnol J 2013;6:e201303018. [PMID: 24688726 DOI: 10.5936/csbj.201303018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
472 Steinhilber D, Fischer AS, Metzner J, Steinbrink SD, Roos J, Ruthardt M, Maier TJ. 5-lipoxygenase: underappreciated role of a pro-inflammatory enzyme in tumorigenesis. Front Pharmacol 2010;1:143. [PMID: 21833182 DOI: 10.3389/fphar.2010.00143] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
473 Filep JG, Ariel A. Neutrophil heterogeneity and fate in inflamed tissues: implications for the resolution of inflammation. Am J Physiol Cell Physiol 2020;319:C510-32. [PMID: 32667864 DOI: 10.1152/ajpcell.00181.2020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
474 Wan M, Soehnlein O, Tang X, van der Does AM, Smedler E, Uhlén P, Lindbom L, Agerberth B, Haeggström JZ. Cathelicidin LL-37 induces time-resolved release of LTB4 and TXA2 by human macrophages and triggers eicosanoid generation in vivo. FASEB J 2014;28:3456-67. [PMID: 24736410 DOI: 10.1096/fj.14-251306] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
475 Mazumder B, Li X, Barik S. Translation control: a multifaceted regulator of inflammatory response. J Immunol 2010;184:3311-9. [PMID: 20304832 DOI: 10.4049/jimmunol.0903778] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
476 Barbaro KC, Lira MS, Araújo CA, Pareja-santos A, Távora BC, Prezotto-neto JP, Kimura LF, Lima C, Lopes-ferreira M, Santoro ML. Inflammatory mediators generated at the site of inoculation of Loxosceles gaucho spider venom. Toxicon 2010;56:972-9. [DOI: 10.1016/j.toxicon.2010.06.022] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
477 Flock MR, Rogers CJ, Prabhu KS, Kris-Etherton PM. Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation. Diabetes Metab Res Rev 2013;29:431-45. [PMID: 23592441 DOI: 10.1002/dmrr.2414] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
478 de Freitas DDN, Marinho Franceschina C, Muller D, Hilario GT, Gassen RB, Fazolo T, de Lima Kaminski V, Bogo Chies JA, Maito F, Antunes KH, Zanin RF, Rodrigues LC Jr, Duarte de Souza AP. RvD1 treatment during primary infection modulates memory response increasing viral load during respiratory viral reinfection. Immunobiology 2021;226:152151. [PMID: 34742024 DOI: 10.1016/j.imbio.2021.152151] [Reference Citation Analysis]
479 Kucharzik T, Gewirtz AT, Merlin D, Madara JL, Williams IR. Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium. Am J Physiol Cell Physiol 2003;284:C888-96. [PMID: 12456400 DOI: 10.1152/ajpcell.00507.2001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
480 Ogawa M, Ishihara T, Isobe Y, Kato T, Kuba K, Imai Y, Uchino Y, Tsubota K, Arita M. Eosinophils promote corneal wound healing via the 12/15-lipoxygenase pathway. FASEB J 2020;34:12492-501. [PMID: 32721046 DOI: 10.1096/fj.202000483R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
481 Dalli J, Serhan CN. Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. Br J Pharmacol 2019;176:1024-37. [PMID: 29679485 DOI: 10.1111/bph.14336] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 14.3] [Reference Citation Analysis]
482 Takiuchi T, Blake EA, Matsuo K, Sood AK, Brasky TM. Aspirin use and endometrial cancer risk and survival. Gynecol Oncol 2018;148:222-32. [PMID: 29132875 DOI: 10.1016/j.ygyno.2017.10.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
483 Higgins G, Ringholz F, Buchanan P, McNally P, Urbach V. Physiological impact of abnormal lipoxin A₄ production on cystic fibrosis airway epithelium and therapeutic potential. Biomed Res Int 2015;2015:781087. [PMID: 25866809 DOI: 10.1155/2015/781087] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
484 El Kholy K, Freire M, Chen T, Van Dyke TE. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions. Front Immunol 2018;9:1300. [PMID: 29946319 DOI: 10.3389/fimmu.2018.01300] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
485 Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM, Serhan CN. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 2002;8:1018-23. [PMID: 12172542 DOI: 10.1038/nm748] [Cited by in Crossref: 265] [Cited by in F6Publishing: 251] [Article Influence: 13.3] [Reference Citation Analysis]
486 Recchiuti A, Serhan CN. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Front Immunol. 2012;3:298. [PMID: 23093949 DOI: 10.3389/fimmu.2012.00298] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
487 Gilroy DW, Stables M, Newson J. In Vivo Models to Study Cyclooxygenase Products in Health and Disease: Introduction to Part III. In: Ayoub SS, Flower RJ, Seed MP, editors. Cyclooxygenases. Totowa: Humana Press; 2010. pp. 181-8. [DOI: 10.1007/978-1-59745-364-6_15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
488 Li G, Wu P, Xu Y, Yu Y, Sun L, Zhu L, Ye D. The effect of Lipoxin A4 on the interaction between macrophage and osteoblast: possible role in the treatment of aseptic loosening. BMC Musculoskelet Disord 2009;10:57. [PMID: 19490628 DOI: 10.1186/1471-2474-10-57] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
489 Damazo AS, Yona S, Flower RJ, Perretti M, Oliani SM. Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J Immunol 2006;176:4410-8. [PMID: 16547279 DOI: 10.4049/jimmunol.176.7.4410] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 5.0] [Reference Citation Analysis]
490 Yuki S, Uemura A, Hakozaki M, Yano A, Abe M, Misawa Y, Baba N, Yamada H. Identification of a novel enzyme from E. pacifica that acts as an eicosapentaenoic 8R-LOX and docosahexaenoic 10R-LOX. Sci Rep 2020;10:20592. [PMID: 33244101 DOI: 10.1038/s41598-020-77386-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
491 [DOI: 10.1101/205997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
492 Giudetti AM, Cagnazzo R. Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases. Prostaglandins & Other Lipid Mediators 2012;99:57-67. [DOI: 10.1016/j.prostaglandins.2012.09.006] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
493 Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier JP. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 2003;62:501-509. [PMID: 12759283 DOI: 10.1136/ard.62.6.501] [Cited by in Crossref: 255] [Cited by in F6Publishing: 232] [Article Influence: 13.4] [Reference Citation Analysis]
494 López-vicario C, Rius B, Alcaraz-quiles J, García-alonso V, Lopategi A, Titos E, Clària J. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases. European Journal of Pharmacology 2016;785:133-43. [DOI: 10.1016/j.ejphar.2015.03.092] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 8.2] [Reference Citation Analysis]
495 Dalli J, Winkler JW, Colas RA, Arnardottir H, Cheng CY, Chiang N, Petasis NA, Serhan CN. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem Biol 2013;20:188-201. [PMID: 23438748 DOI: 10.1016/j.chembiol.2012.11.010] [Cited by in Crossref: 145] [Cited by in F6Publishing: 139] [Article Influence: 16.1] [Reference Citation Analysis]
496 Mariani F, Sena P, Marzona L, Riccio M, Fano R, Manni P, Gregorio CD, Pezzi A, Leon MP, Monni S. Cyclooxygenase-2 and Hypoxia-Inducible Factor-1alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis. Cancer Lett. 2009;279:221-229. [PMID: 19268443 DOI: 10.1016/j.canlet.2009.02.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
497 Zong L, Li J, Chen X, Chen K, Li W, Li X, Zhang L, Duan W, Lei J, Xu Q, Shan T, Ma Q, Sun H. Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer. Oxid Med Cell Longev 2016;2016:6815727. [PMID: 26649143 DOI: 10.1155/2016/6815727] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
498 Kunikata T, Yamane H, Segi E, Matsuoka T, Sugimoto Y, Tanaka S, Tanaka H, Nagai H, Ichikawa A, Narumiya S. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol 2005;6:524-31. [PMID: 15806106 DOI: 10.1038/ni1188] [Cited by in Crossref: 172] [Cited by in F6Publishing: 149] [Article Influence: 10.1] [Reference Citation Analysis]
499 Malachowa N, Kobayashi SD, Quinn MT, DeLeo FR. NET Confusion. Front Immunol 2016;7:259. [PMID: 27446089 DOI: 10.3389/fimmu.2016.00259] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
500 Das UN. Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2013;42:122-34. [DOI: 10.1016/j.pnpbp.2012.06.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
501 Pierdomenico AM, Recchiuti A, Simiele F, Codagnone M, Mari VC, Davì G, Romano M. MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages. J Biol Chem 2015;290:3592-600. [PMID: 25505240 DOI: 10.1074/jbc.M114.592352] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
502 Aliberti J. Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nat Rev Immunol 2005;5:162-70. [PMID: 15662369 DOI: 10.1038/nri1547] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 5.4] [Reference Citation Analysis]
503 Balta MG, Papathanasiou E, Christopoulos PF. Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19. Front Immunol 2021;12:632238. [PMID: 33717168 DOI: 10.3389/fimmu.2021.632238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
504 Yaqoob P. Lipids and the immune response: from molecular mechanisms to clinical applications: . Current Opinion in Clinical Nutrition and Metabolic Care 2003;6:133-50. [DOI: 10.1097/00075197-200303000-00002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
505 Sahanic S, Löffler-Ragg J, Tymoszuk P, Hilbe R, Demetz E, Masanetz RK, Theurl M, Holfeld J, Gollmann-Tepeköylü C, Tzankov A, Weiss G, Giera M, Tancevski I. The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza. Front Physiol 2021;12:688946. [PMID: 34366882 DOI: 10.3389/fphys.2021.688946] [Reference Citation Analysis]
506 Chen QH, Zhou WD, Pu DM, Huang QS, Li T, Chen QX. 15-Epi-lipoxin A(4) inhibits the progression of endometriosis in a murine model. Fertil Steril 2010;93:1440-7. [PMID: 19268934 DOI: 10.1016/j.fertnstert.2009.01.107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
507 Bang S, Yoo S, Oh U, Hwang SW. Endogenous lipid-derived ligands for sensory TRP ion channels and their pain modulation. Arch Pharm Res 2010;33:1509-20. [DOI: 10.1007/s12272-010-1004-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
508 Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol. 2007;179:7021-7029. [PMID: 17982093 DOI: 10.4049/jimmunol.179.10.7021] [Cited by in Crossref: 282] [Cited by in F6Publishing: 264] [Article Influence: 18.8] [Reference Citation Analysis]
509 Wang H, Anthony D, Selemidis S, Vlahos R, Bozinovski S. Resolving Viral-Induced Secondary Bacterial Infection in COPD: A Concise Review. Front Immunol 2018;9:2345. [PMID: 30459754 DOI: 10.3389/fimmu.2018.02345] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
510 Usher KM, Zhu S, Mavropalias G, Carrino JA, Zhao J, Xu J. Pathological mechanisms and therapeutic outlooks for arthrofibrosis. Bone Res 2019;7:9. [PMID: 30937213 DOI: 10.1038/s41413-019-0047-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
511 Dakin SG, Dudhia J, Werling NJ, Werling D, Abayasekara DR, Smith RK. Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease. PLoS One 2012;7:e48978. [PMID: 23155437 DOI: 10.1371/journal.pone.0048978] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
512 Kamaly N, Fredman G, Subramanian M, Gadde S, Pesic A, Cheung L, Fayad ZA, Langer R, Tabas I, Farokhzad OC. Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles. Proc Natl Acad Sci U S A 2013;110:6506-11. [PMID: 23533277 DOI: 10.1073/pnas.1303377110] [Cited by in Crossref: 136] [Cited by in F6Publishing: 127] [Article Influence: 15.1] [Reference Citation Analysis]
513 Planagumà A, Titos E, López-Parra M, Gaya J, Pueyo G, Arroyo V, Clària J. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. FASEB J 2002;16:1937-9. [PMID: 12368230 DOI: 10.1096/fj.02-0224fje] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
514 Isaak M, Ulu A, Osunde A, Nordgren TM, Hanson C. Nutritional Factors in Occupational Lung Disease. Curr Allergy Asthma Rep 2021;21:24. [PMID: 33768348 DOI: 10.1007/s11882-021-01003-0] [Reference Citation Analysis]
515 Warner DR, Liu H, Ghosh Dastidar S, Warner JB, Prodhan MAI, Yin X, Zhang X, Feldstein AE, Gao B, Prough RA, McClain CJ, Kirpich IA. Ethanol and unsaturated dietary fat induce unique patterns of hepatic ω-6 and ω-3 PUFA oxylipins in a mouse model of alcoholic liver disease. PLoS One 2018;13:e0204119. [PMID: 30256818 DOI: 10.1371/journal.pone.0204119] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
516 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
517 Peng B, Kopczynski D, Pratt BS, Ejsing CS, Burla B, Hermansson M, Benke PI, Tan SH, Chan MY, Torta F, Schwudke D, Meckelmann SW, Coman C, Schmitz OJ, MacLean B, Manke MC, Borst O, Wenk MR, Hoffmann N, Ahrends R. LipidCreator workbench to probe the lipidomic landscape. Nat Commun 2020;11:2057. [PMID: 32345972 DOI: 10.1038/s41467-020-15960-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
518 Marasca C, Annunziata MC, Napolitano M, Fabbrocini G. Unconventional therapies for hidradenitis suppurativa. Expert Review of Clinical Pharmacology 2018;11:879-87. [DOI: 10.1080/17512433.2018.1509706] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
519 Heyder J, Beck-speier I, Ferron GA, Josten M, Karg E, Kreyling WG, Lenz A, Maier KL, Reitmeier P, Ruprecht L, Takenaka S, Wohland T, Ziesenis A, Schulz H. Long-term responses of canine lungs to acidic particles. Inhalation Toxicology 2009;21:920-32. [DOI: 10.1080/08958370802651994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
520 Vance RE, Hong S, Gronert K, Serhan CN, Mekalanos JJ. The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase. Proc Natl Acad Sci U S A 2004;101:2135-9. [PMID: 14766977 DOI: 10.1073/pnas.0307308101] [Cited by in Crossref: 140] [Cited by in F6Publishing: 128] [Article Influence: 7.8] [Reference Citation Analysis]
521 Turner JA, Paton EL, Van Gulick R, Stefanoni D, Cendali F, Reisz J, Tobin RP, Mccarter M, D’alessandro A, Torres RM, Robinson WA, Couts KL, Schlaepfer IR. BRAF Modulates Lipid Use and Accumulation. Cancers 2022;14:2110. [DOI: 10.3390/cancers14092110] [Reference Citation Analysis]
522 Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Carcinogenesis: Failure of resolution of inflammation? Pharmacol Ther 2021;218:107670. [PMID: 32891711 DOI: 10.1016/j.pharmthera.2020.107670] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
523 Almeida PE, Weber PS, Burton JL, Tempelman RJ, Steibel JP, Zanella AJ. Gene expression profiling of peripheral mononuclear cells in lame dairy cows with foot lesions. Vet Immunol Immunopathol 2007;120:234-45. [PMID: 17675248 DOI: 10.1016/j.vetimm.2007.06.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
524 Abdolmaleki F, Kovanen PT, Mardani R, Gheibi-Hayat SM, Bo S, Sahebkar A. Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases. Clin Rev Allergy Immunol 2020;58:82-91. [PMID: 31267470 DOI: 10.1007/s12016-019-08754-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
525 Croasdell A, Lacy SH, Thatcher TH, Sime PJ, Phipps RP. Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzae. J Immunol 2016;196:2742-52. [PMID: 26843331 DOI: 10.4049/jimmunol.1502331] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
526 Menarim BC, El-Sheikh Ali H, Loux SC, Scoggin KE, Kalbfleisch TS, MacLeod JN, Dahlgren LA. Transcriptional and Histochemical Signatures of Bone Marrow Mononuclear Cell-Mediated Resolution of Synovitis. Front Immunol 2021;12:734322. [PMID: 34956173 DOI: 10.3389/fimmu.2021.734322] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
527 Rey C, Delpech JC, Madore C, Nadjar A, Greenhalgh AD, Amadieu C, Aubert A, Pallet V, Vaysse C, Layé S, Joffre C. Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain. Brain Behav Immun 2019;76:17-27. [PMID: 30086401 DOI: 10.1016/j.bbi.2018.07.025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
528 Taketomi Y, Ueno N, Kojima T, Sato H, Murase R, Yamamoto K, Tanaka S, Sakanaka M, Nakamura M, Nishito Y, Kawana M, Kambe N, Ikeda K, Taguchi R, Nakamizo S, Kabashima K, Gelb MH, Arita M, Yokomizo T, Nakamura M, Watanabe K, Hirai H, Nakamura M, Okayama Y, Ra C, Aritake K, Urade Y, Morimoto K, Sugimoto Y, Shimizu T, Narumiya S, Hara S, Murakami M. Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. Nat Immunol 2013;14:554-63. [PMID: 23624557 DOI: 10.1038/ni.2586] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 9.2] [Reference Citation Analysis]
529 Lukashev DE, Smith PT, Caldwell CC, Ohta A, Apasov SG, Sitkovsky MV. Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs. Biochem Pharmacol 2003;65:2081-90. [PMID: 12787889 DOI: 10.1016/s0006-2952(03)00158-8] [Cited by in Crossref: 57] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
530 Watanabe H, Son M. The Immune Tolerance Role of the HMGB1-RAGE Axis. Cells 2021;10:564. [PMID: 33807604 DOI: 10.3390/cells10030564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
531 Chiurchiù V, Leuti A, Dalli J, Jacobsson A, Battistini L, Maccarrone M, Serhan CN. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Sci Transl Med 2016;8:353ra111. [PMID: 27559094 DOI: 10.1126/scitranslmed.aaf7483] [Cited by in Crossref: 159] [Cited by in F6Publishing: 158] [Article Influence: 31.8] [Reference Citation Analysis]
532 Rago B, Fu C. Development of a high-throughput ultra performance liquid chromatography–mass spectrometry assay to profile 18 eicosanoids as exploratory biomarkers for atherosclerotic diseases. Journal of Chromatography B 2013;936:25-32. [DOI: 10.1016/j.jchromb.2013.08.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
533 Nicolete R, Lima KDM, Júnior JM, Baruffi MD, de Medeiros AI, Bentley MV, Silva CL, Faccioli LH. In vitro and in vivo activities of leukotriene B4-loaded biodegradable microspheres. Prostaglandins & Other Lipid Mediators 2007;83:121-9. [DOI: 10.1016/j.prostaglandins.2006.10.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
534 Mangino MJ, Brounts L, Harms B, Heise C. Lipoxin biosynthesis in inflammatory bowel disease. Prostaglandins Other Lipid Mediat. 2006;79:84-92. [PMID: 16516812 DOI: 10.1016/j.prostaglandins.2005.10.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
535 Whittington RA, Planel E, Terrando N. Impaired Resolution of Inflammation in Alzheimer's Disease: A Review. Front Immunol 2017;8:1464. [PMID: 29163531 DOI: 10.3389/fimmu.2017.01464] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
536 Masoodi M, Pearl DS, Eiden M, Shute JK, Brown JF, Calder PC, Trebble TM. Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology. PLoS One 2013;8:e76532. [PMID: 24204637 DOI: 10.1371/journal.pone.0076532] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
537 Calder PC. Dietary arachidonic acid: harmful, harmless or helpful? Br J Nutr 2007;98:451-3. [PMID: 17705889 DOI: 10.1017/S0007114507761779] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
538 Ortiz-Muñoz G, Mallavia B, Bins A, Headley M, Krummel MF, Looney MR. Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. Blood 2014;124:2625-34. [PMID: 25143486 DOI: 10.1182/blood-2014-03-562876] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 13.3] [Reference Citation Analysis]
539 Das >N. Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II. Clinical Lipidology 2013;8:465-80. [DOI: 10.2217/clp.13.32] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
540 Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2015;7:a016311. [PMID: 25359497 DOI: 10.1101/cshperspect.a016311] [Cited by in Crossref: 218] [Cited by in F6Publishing: 208] [Article Influence: 27.3] [Reference Citation Analysis]
541 Clària J, Nguyen BT, Madenci AL, Ozaki CK, Serhan CN. Diversity of lipid mediators in human adipose tissue depots. Am J Physiol Cell Physiol 2013;304:C1141-9. [PMID: 23364264 DOI: 10.1152/ajpcell.00351.2012] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 9.8] [Reference Citation Analysis]
542 Zolk O, Hafner S, Schmidt CQ; German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT). COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1131-5. [PMID: 32415494 DOI: 10.1007/s00210-020-01890-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
543 Mirzaei R, Sabokroo N, Ahmadyousefi Y, Motamedi H, Karampoor S. Immunometabolism in biofilm infection: lessons from cancer. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00435-2] [Reference Citation Analysis]
544 Botten N, Hodges RR, Li D, Bair JA, Shatos MA, Utheim TP, Serhan CN, Dartt DA. Resolvin D2 elevates cAMP to increase intracellular [Ca2+] and stimulate secretion from conjunctival goblet cells. FASEB J 2019;33:8468-78. [PMID: 31013438 DOI: 10.1096/fj.201802467R] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
545 Havixbeck JJ, Rieger AM, Wong ME, Hodgkinson JW, Barreda DR. Neutrophil contributions to the induction and regulation of the acute inflammatory response in teleost fish. J Leukoc Biol 2016;99:241-52. [PMID: 26292979 DOI: 10.1189/jlb.3HI0215-064R] [Cited by in Crossref: 45] [Cited by in F6Publishing: 13] [Article Influence: 6.4] [Reference Citation Analysis]
546 Dennis EA, Norris PC. Eicosanoid storm in infection and inflammation. Nat Rev Immunol 2015;15:511-23. [PMID: 26139350 DOI: 10.1038/nri3859] [Cited by in Crossref: 636] [Cited by in F6Publishing: 589] [Article Influence: 90.9] [Reference Citation Analysis]
547 Pouliot M, Fiset ME, Massé M, Naccache PH, Borgeat P. Adenosine up-regulates cyclooxygenase-2 in human granulocytes: impact on the balance of eicosanoid generation. J Immunol 2002;169:5279-86. [PMID: 12391247 DOI: 10.4049/jimmunol.169.9.5279] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
548 Nalini N, Aranganathan S, Kabalimurthy J. Chemopreventive efficacy of hesperetin (citrus flavonone) against 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Toxicol Mech Methods 2012;22:397-408. [PMID: 22409373 DOI: 10.3109/15376516.2012.673092] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
549 Gangemi S, Pescara L, D'Urbano E, Basile G, Nicita-Mauro V, Davì G, Romano M. Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Exp Gerontol. 2005;40:612-614. [PMID: 15935589 DOI: 10.1016/j.exger.2005.04.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 2.9] [Reference Citation Analysis]
550 Lee HN, Na HK, Surh YJ. Resolution of inflammation as a novel chemopreventive strategy. Semin Immunopathol 2013;35:151-61. [PMID: 23370700 DOI: 10.1007/s00281-013-0363-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
551 Tyurina YY, St Croix CM, Watkins SC, Watson AM, Epperly MW, Anthonymuthu TS, Kisin ER, Vlasova II, Krysko O, Krysko DV, Kapralov AA, Dar HH, Tyurin VA, Amoscato AA, Popova EN, Bolevich SB, Timashev PS, Kellum JA, Wenzel SE, Mallampalli RK, Greenberger JS, Bayir H, Shvedova AA, Kagan VE. Redox (phospho)lipidomics of signaling in inflammation and programmed cell death. J Leukoc Biol 2019;106:57-81. [PMID: 31071242 DOI: 10.1002/JLB.3MIR0119-004RR] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
552 Bender EC, Kraynak CA, Huang W, Suggs LJ. Cell-Inspired Biomaterials for Modulating Inflammation. Tissue Eng Part B Rev 2021. [PMID: 33528306 DOI: 10.1089/ten.TEB.2020.0276] [Reference Citation Analysis]
553 Uddin M, Levy BD. Resolvins: natural agonists for resolution of pulmonary inflammation. Prog Lipid Res 2011;50:75-88. [PMID: 20887750 DOI: 10.1016/j.plipres.2010.09.002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
554 Lacy SH, Woeller CF, Thatcher TH, Maddipati KR, Honn KV, Sime PJ, Phipps RP. Human lung fibroblasts produce proresolving peroxisome proliferator-activated receptor-γ ligands in a cyclooxygenase-2-dependent manner. Am J Physiol Lung Cell Mol Physiol 2016;311:L855-67. [PMID: 27612965 DOI: 10.1152/ajplung.00272.2016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
555 Bruegel M, Ludwig U, Kleinhempel A, Petros S, Kortz L, Ceglarek U, Holdt LM, Thiery J, Fiedler GM. Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients. Crit Care Med. 2012;40:1478-1486. [PMID: 22511130 DOI: 10.1097/ccm.0b013e3182416f05] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
556 Menschikowski M, Hagelgans A, Siegert G. Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Prostaglandins & Other Lipid Mediators 2006;79:1-33. [DOI: 10.1016/j.prostaglandins.2005.10.005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 74] [Article Influence: 5.8] [Reference Citation Analysis]
557 Nayak S, Al Ashhab A, Zilberg D, Khozin-Goldberg I. Dietary Supplementation with Omega-6 LC-PUFA-Rich Microalgae Regulates Mucosal Immune Response and Promotes Microbial Diversity in the Zebrafish Gut. Biology (Basel) 2020;9:E119. [PMID: 32517017 DOI: 10.3390/biology9060119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
558 Blaho VA, Mitchell WJ, Brown CR. Arthritis develops but fails to resolve during inhibition of cyclooxygenase 2 in a murine model of Lyme disease. Arthritis Rheum 2008;58:1485-95. [PMID: 18438879 DOI: 10.1002/art.23371] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
559 Maile MD, Standiford TJ, Engoren MC, Stringer KA, Jewell ES, Rajendiran TM, Soni T, Burant CF. Associations of the plasma lipidome with mortality in the acute respiratory distress syndrome: a longitudinal cohort study. Respir Res 2018;19:60. [PMID: 29636049 DOI: 10.1186/s12931-018-0758-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
560 Abumrad NA, Piomelli D, Yurko-Mauro K, Merrill A, Clandinin MT, Serhan CN. Moving beyond "good fat, bad fat": the complex roles of dietary lipids in cellular function and health: session abstracts. Adv Nutr 2012;3:60-8. [PMID: 22332103 DOI: 10.3945/an.111.000802] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
561 Wolfer AM, Gaudin M, Taylor-Robinson SD, Holmes E, Nicholson JK. Development and Validation of a High-Throughput Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry Approach for Screening of Oxylipins and Their Precursors. Anal Chem 2015;87:11721-31. [PMID: 26501362 DOI: 10.1021/acs.analchem.5b02794] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
562 Welty FK. New Areas of Interest: Is There a Role for Omega-3 Fatty Acid Supplementation in Patients With Diabetes and Cardiovascular Disease? Curr Diab Rep 2019;19:6. [PMID: 30684085 DOI: 10.1007/s11892-019-1126-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
563 Das UN. Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review. J Adv Res 2018;11:43-55. [PMID: 30034875 DOI: 10.1016/j.jare.2018.01.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
564 Brennan E, Mohan M, Andrews D, Bose M, Kantharidis P. Specialized pro-resolving mediators in diabetes: novel therapeutic strategies. Clinical Science 2019;133:2121-41. [DOI: 10.1042/cs20190067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
565 Davies CL, Patir A, McColl BW. Myeloid Cell and Transcriptome Signatures Associated With Inflammation Resolution in a Model of Self-Limiting Acute Brain Inflammation. Front Immunol. 2019;10:1048. [PMID: 31156629 DOI: 10.3389/fimmu.2019.01048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
566 Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010;10:427-439. [PMID: 20498669 DOI: 10.1038/nri2779] [Cited by in Crossref: 612] [Cited by in F6Publishing: 602] [Article Influence: 51.0] [Reference Citation Analysis]
567 Yoo S, Lim JY, Hwang SW. Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives. Curr Neuropharmacol 2013;11:664-76. [PMID: 24396341 DOI: 10.2174/1570159X11311060009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
568 Hsiao HM, Thatcher TH, Levy EP, Fulton RA, Owens KM, Phipps RP, Sime PJ. Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1. J Immunol 2014;193:4980-7. [PMID: 25320283 DOI: 10.4049/jimmunol.1400313] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
569 West EE, Kunz N, Kemper C. Complement and human T cell metabolism: Location, location, location. Immunol Rev 2020;295:68-81. [PMID: 32166778 DOI: 10.1111/imr.12852] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
570 Fattori V, Ferraz CR, Rasquel-Oliveira FS, Verri WA Jr. Neuroimmune communication in infection and pain: Friends or foes? Immunol Lett 2021;229:32-43. [PMID: 33248166 DOI: 10.1016/j.imlet.2020.11.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
571 García-Alonso V, Titos E, Alcaraz-Quiles J, Rius B, Lopategi A, López-Vicario C, Jakobsson PJ, Delgado S, Lozano J, Clària J. Prostaglandin E2 Exerts Multiple Regulatory Actions on Human Obese Adipose Tissue Remodeling, Inflammation, Adaptive Thermogenesis and Lipolysis. PLoS One 2016;11:e0153751. [PMID: 27124181 DOI: 10.1371/journal.pone.0153751] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
572 Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem. 2003;278:14677-14687. [PMID: 12590139 DOI: 10.1074/jbc.m300218200] [Cited by in Crossref: 711] [Cited by in F6Publishing: 314] [Article Influence: 37.4] [Reference Citation Analysis]
573 Calder PC. Eicosanoids. Essays Biochem 2020;64:423-41. [PMID: 32808658 DOI: 10.1042/EBC20190083] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
574 Perretti M, Leroy X, Bland EJ, Montero-Melendez T. Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation. Trends Pharmacol Sci 2015;36:737-55. [PMID: 26478210 DOI: 10.1016/j.tips.2015.07.007] [Cited by in Crossref: 109] [Cited by in F6Publishing: 97] [Article Influence: 15.6] [Reference Citation Analysis]
575 Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 2012;120:e60-72. [PMID: 22904297 DOI: 10.1182/blood-2012-04-423525] [Cited by in Crossref: 314] [Cited by in F6Publishing: 307] [Article Influence: 31.4] [Reference Citation Analysis]
576 Morris G, Berk M, Walder K, O'Neil A, Maes M, Puri BK. The lipid paradox in neuroprogressive disorders: Causes and consequences. Neurosci Biobehav Rev 2021;128:35-57. [PMID: 34118292 DOI: 10.1016/j.neubiorev.2021.06.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
577 Monneret G, Li H, Vasilescu J, Rokach J, Powell WS. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol 2002;168:3563-9. [PMID: 11907120 DOI: 10.4049/jimmunol.168.7.3563] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 4.4] [Reference Citation Analysis]
578 Shoieb SM, El-Ghiaty MA, El-Kadi AOS. Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles. Emergent Mater 2020;:1-13. [PMID: 33225219 DOI: 10.1007/s42247-020-00136-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
579 Tateishi N, Kakutani S, Kawashima H, Shibata H, Morita I. Dietary supplementation of arachidonic acid increases arachidonic acid and lipoxin A₄ contents in colon, but does not affect severity or prostaglandin E₂ content in murine colitis model. Lipids Health Dis 2014;13:30. [PMID: 24507383 DOI: 10.1186/1476-511X-13-30] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
580 Shiraishi Y, Asano K, Niimi K, Fukunaga K, Wakaki M, Kagyo J, Takihara T, Ueda S, Nakajima T, Oguma T, Suzuki Y, Shiomi T, Sayama K, Kagawa S, Ikeda E, Hirai H, Nagata K, Nakamura M, Miyasho T, Ishizaka A. Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. J Immunol 2008;180:541-9. [PMID: 18097056 DOI: 10.4049/jimmunol.180.1.541] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
581 Buchanan PJ, McNally P, Harvey BJ, Urbach V. Lipoxin A₄-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair. Am J Physiol Lung Cell Mol Physiol 2013;305:L193-201. [PMID: 23686859 DOI: 10.1152/ajplung.00058.2013] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
582 Barnig C, Frossard N, Levy BD. Towards targeting resolution pathways of airway inflammation in asthma. Pharmacol Ther 2018;186:98-113. [PMID: 29352860 DOI: 10.1016/j.pharmthera.2018.01.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
583 Li Y, Karlin A, Loike JD, Silverstein SC. Determination of the critical concentration of neutrophils required to block bacterial growth in tissues. J Exp Med 2004;200:613-22. [PMID: 15353554 DOI: 10.1084/jem.20040725] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
584 Beck-speier I, Dayal N, Karg E, Maier KL, Schumann G, Semmler M, Koelsch SM. Oxymetazoline Inhibits Proinflammatory Reactions: Effect on Arachidonic Acid-Derived Metabolites. J Pharmacol Exp Ther 2006;316:843-51. [DOI: 10.1124/jpet.105.093278] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
585 Das UN. Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids. Lipids Health Dis 2016;15:11. [PMID: 26762544 DOI: 10.1186/s12944-015-0165-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
586 Vago JP, Amaral FA, van de Loo FAJ. Resolving inflammation by TAM receptor activation. Pharmacol Ther 2021;227:107893. [PMID: 33992683 DOI: 10.1016/j.pharmthera.2021.107893] [Reference Citation Analysis]
587 Yamamoto M, Aizawa R. Maintaining a protective state for human periodontal tissue. Periodontol 2000 2021;86:142-56. [PMID: 33690927 DOI: 10.1111/prd.12367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
588 Lumbroso D, Soboh S, Maimon A, Schif-Zuck S, Ariel A, Burstyn-Cohen T. Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages and Supports Their Reprogramming. Front Immunol 2018;9:358. [PMID: 29545796 DOI: 10.3389/fimmu.2018.00358] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
589 Flamand N, Surette ME, Picard S, Bourgoin S, Borgeat P. Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils. Mol Pharmacol 2002;62:250-6. [PMID: 12130675 DOI: 10.1124/mol.62.2.250] [Cited by in Crossref: 96] [Cited by in F6Publishing: 92] [Article Influence: 4.8] [Reference Citation Analysis]
590 Grainger JR, Konkel JE, Zangerle-Murray T, Shaw TN. Macrophages in gastrointestinal homeostasis and inflammation. Pflugers Arch 2017;469:527-39. [PMID: 28283748 DOI: 10.1007/s00424-017-1958-2] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
591 Liu Y, Wei L, He C, Chen R, Meng L. Lipoxin A4 inhibits ovalbumin-induced airway inflammation and airway remodeling in a mouse model of asthma. Chem Biol Interact 2021;349:109660. [PMID: 34537180 DOI: 10.1016/j.cbi.2021.109660] [Reference Citation Analysis]
592 Karp CL, Flick LM, Yang R, Uddin J, Petasis NA. Cystic fibrosis and lipoxins. Prostaglandins Leukot Essent Fatty Acids 2005;73:263-70. [PMID: 15979866 DOI: 10.1016/j.plefa.2005.05.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
593 Rieger AM, Konowalchuk JD, Grayfer L, Katzenback BA, Havixbeck JJ, Kiemele MD, Belosevic M, Barreda DR. Fish and mammalian phagocytes differentially regulate pro-inflammatory and homeostatic responses in vivo. PLoS One 2012;7:e47070. [PMID: 23110059 DOI: 10.1371/journal.pone.0047070] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
594 Gan H, Lee J, Ren F, Chen M, Kornfeld H, Remold HG. Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol 2008;9:1189-97. [PMID: 18794848 DOI: 10.1038/ni.1654] [Cited by in Crossref: 137] [Cited by in F6Publishing: 140] [Article Influence: 9.8] [Reference Citation Analysis]
595 Kovarova M, Koller BH. PGE₂ promotes apoptosis induced by cytokine deprivation through EP3 receptor and induces Bim in mouse mast cells. PLoS One 2014;9:e102948. [PMID: 25054560 DOI: 10.1371/journal.pone.0102948] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
596 Hsiao HM, Thatcher TH, Colas RA, Serhan CN, Phipps RP, Sime PJ. Resolvin D1 Reduces Emphysema and Chronic Inflammation. Am J Pathol. 2015;185:3189-3201. [PMID: 26468975 DOI: 10.1016/j.ajpath.2015.08.008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
597 Chen M, Divangahi M, Gan H, Shin DS, Hong S, Lee DM, Serhan CN, Behar SM, Remold HG. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med 2008;205:2791-801. [PMID: 18955568 DOI: 10.1084/jem.20080767] [Cited by in Crossref: 232] [Cited by in F6Publishing: 223] [Article Influence: 16.6] [Reference Citation Analysis]
598 de Fáveri C, Fermino PMP, Piovezan AP, Volpato LK. The Inflammatory Role of Pro-Resolving Mediators in Endometriosis: An Integrative Review. Int J Mol Sci 2021;22:4370. [PMID: 33922064 DOI: 10.3390/ijms22094370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
599 Kieran NE, Maderna P, Godson C. Lipoxins: Potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. Kidney International 2004;65:1145-54. [DOI: 10.1111/j.1523-1755.2004.00487.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.0] [Reference Citation Analysis]
600 Berger EA. Understanding the Role of Pro-resolving Lipid Mediators in Infectious Keratitis. Adv Exp Med Biol 2019;1161:3-12. [PMID: 31562617 DOI: 10.1007/978-3-030-21735-8_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
601 Van Dyke TE, van Winkelhoff AJ. Infection and inflammatory mechanisms. J Periodontol 2013;84:S1-7. [PMID: 23631571 DOI: 10.1902/jop.2013.1340018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
602 Haworth O, Levy BD. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007;30:980-92. [PMID: 17978156 DOI: 10.1183/09031936.00005807] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
603 Calder PC. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake. Biochimie 2020;178:105-23. [PMID: 32860894 DOI: 10.1016/j.biochi.2020.08.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
604 Barker G, Leeuwenburgh C, Brusko T, Moldawer L, Reddy ST, Guirgis FW. Lipid and Lipoprotein Dysregulation in Sepsis: Clinical and Mechanistic Insights into Chronic Critical Illness. J Clin Med 2021;10:1693. [PMID: 33920038 DOI: 10.3390/jcm10081693] [Reference Citation Analysis]
605 Ayub M, Jin HK, Bae J. Sphingosine kinase-dependent regulation of pro-resolving lipid mediators in Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2022. [DOI: 10.1016/j.bbalip.2022.159126] [Reference Citation Analysis]
606 Plante H, Picard S, Mancini J, Borgeat P. 5-Lipoxygenase-activating protein homodimer in human neutrophils: evidence for a role in leukotriene biosynthesis. Biochem J 2006;393:211-8. [PMID: 16144515 DOI: 10.1042/BJ20050669] [Cited by in Crossref: 28] [Article Influence: 1.8] [Reference Citation Analysis]
607 Chiang N, de la Rosa X, Libreros S, Serhan CN. Novel Resolvin D2 Receptor Axis in Infectious Inflammation. J Immunol 2017;198:842-51. [PMID: 27994074 DOI: 10.4049/jimmunol.1601650] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 12.8] [Reference Citation Analysis]
608 Krämer J, Kang R, Grimm LM, De Cola L, Picchetti P, Biedermann F. Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids. Chem Rev 2022. [PMID: 34995461 DOI: 10.1021/acs.chemrev.1c00746] [Reference Citation Analysis]
609 Hilliard KA, Blaho VA, Jackson CD, Brown CR. Leukotriene B4 receptor BLT1 signaling is critical for neutrophil apoptosis and resolution of experimental Lyme arthritis. FASEB J 2020;34:2840-52. [PMID: 31908031 DOI: 10.1096/fj.201902014R] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
610 Elajami TK, Colas RA, Dalli J, Chiang N, Serhan CN, Welty FK. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. FASEB J 2016;30:2792-801. [PMID: 27121596 DOI: 10.1096/fj.201500155R] [Cited by in Crossref: 72] [Cited by in F6Publishing: 48] [Article Influence: 12.0] [Reference Citation Analysis]
611 Duvall MG, Levy BD. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol 2016;785:144-55. [PMID: 26546247 DOI: 10.1016/j.ejphar.2015.11.001] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 15.1] [Reference Citation Analysis]
612 Kubat NJ, Moffett J, Fray LM. Effect of pulsed electromagnetic field treatment on programmed resolution of inflammation pathway markers in human cells in culture. J Inflamm Res 2015;8:59-69. [PMID: 25759595 DOI: 10.2147/JIR.S78631] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
613 Mancini AD, Di Battista JA. The cardinal role of the phospholipase A2/cyclooxygenase-2/prostaglandin E synthase/prostaglandin E2 (PCPP) axis in inflammostasis. Inflamm Res 2011;60:1083-92. [DOI: 10.1007/s00011-011-0385-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
614 Piotrowska-tomala K, Siemieniuch M, Szóstek A, Korzekwa A, Woclawek-potocka I, Galváo A, Okuda K, Skarzynski D. Lipopolysaccharides, cytokines, and nitric oxide affect secretion of prostaglandins and leukotrienes by bovine mammary gland epithelial cells. Domestic Animal Endocrinology 2012;43:278-88. [DOI: 10.1016/j.domaniend.2012.04.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
615 Nicolaou A. Eicosanoids in skin inflammation. Prostaglandins Leukot Essent Fatty Acids 2013;88:131-8. [PMID: 22521864 DOI: 10.1016/j.plefa.2012.03.009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
616 Holopainen M, Colas RA, Valkonen S, Tigistu-sahle F, Hyvärinen K, Mazzacuva F, Lehenkari P, Käkelä R, Dalli J, Kerkelä E, Laitinen S. Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019;1864:1350-62. [DOI: 10.1016/j.bbalip.2019.06.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
617 Papathanasiou E, Trotman CA, Scott AR, Van Dyke TE. Current and Emerging Treatments for Postsurgical Cleft Lip Scarring: Effectiveness and Mechanisms. J Dent Res 2017;96:1370-7. [PMID: 28650705 DOI: 10.1177/0022034517717261] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
618 Fredman G, Tabas I. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy. Am J Pathol 2017;187:1211-21. [PMID: 28527709 DOI: 10.1016/j.ajpath.2017.01.018] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 17.4] [Reference Citation Analysis]
619 Chen QH, Zhou WD, Su ZY, Huang QS, Jiang JN, Chen QX. Change of proinflammatory cytokines follows certain patterns after induction of endometriosis in a mouse model. Fertil Steril 2010;93:1448-54. [PMID: 19342044 DOI: 10.1016/j.fertnstert.2009.02.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
620 Calder PC, Deckelbaum RJ. Fat as a physiological regulator: the news gets better: . Current Opinion in Clinical Nutrition and Metabolic Care 2003;6:127-31. [DOI: 10.1097/00075197-200303000-00001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
621 Lee S, Nakahira K, Dalli J, Siempos II, Norris PC, Colas RA, Moon JS, Shinohara M, Hisata S, Howrylak JA, Suh GY, Ryter SW, Serhan CN, Choi AMK. NLRP3 Inflammasome Deficiency Protects against Microbial Sepsis via Increased Lipoxin B4 Synthesis. Am J Respir Crit Care Med 2017;196:713-26. [PMID: 28245134 DOI: 10.1164/rccm.201604-0892OC] [Cited by in Crossref: 69] [Cited by in F6Publishing: 47] [Article Influence: 13.8] [Reference Citation Analysis]
622 Das UN. Inflammation. Molecular Basis of Health and Disease. Dordrecht: Springer Netherlands; 2011. pp. 15-100. [DOI: 10.1007/978-94-007-0495-4_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
623 Vong L, Ferraz JG, Dufton N, Panaccione R, Beck PL, Sherman PM, Perretti M, Wallace JL. Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis. PLoS One. 2012;7:e39244. [PMID: 22723974 DOI: 10.1371/journal.pone.0039244] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
624 Markworth JF, Vella L, Lingard BS, Tull DL, Rupasinghe TW, Sinclair AJ, Maddipati KR, Cameron-Smith D. Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. Am J Physiol Regul Integr Comp Physiol 2013;305:R1281-96. [PMID: 24089379 DOI: 10.1152/ajpregu.00128.2013] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 10.1] [Reference Citation Analysis]
625 Clish CB, Sun YP, Serhan CN. Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase. Biochem Biophys Res Commun 2001;288:868-74. [PMID: 11688989 DOI: 10.1006/bbrc.2001.5841] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
626 Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt B, Szczeklik W, Drazen JM, Serhan CN. Lipoxins and Aspirin-Triggered Lipoxins in Airway Responses. In: Yazici Z, Folco GC, Drazen JM, Nigam S, Shimizu T, editors. Advances in Prostaglandin, Leukotriene, and other Bioactive Lipid Research. Boston: Springer US; 2003. pp. 19-23. [DOI: 10.1007/978-1-4419-9194-2_5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
627 Körner A, Schlegel M, Kaussen T, Gudernatsch V, Hansmann G, Schumacher T, Giera M, Mirakaj V. Sympathetic nervous system controls resolution of inflammation via regulation of repulsive guidance molecule A. Nat Commun 2019;10:633. [PMID: 30733433 DOI: 10.1038/s41467-019-08328-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
628 Planagumà A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, Bleecker ER, Curran-Everett D, Erzurum SC, Calhoun WJ, Castro M, Chung KF, Gaston B, Jarjour NN, Busse WW, Wenzel SE, Levy BD. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008;178:574-82. [PMID: 18583575 DOI: 10.1164/rccm.200801-061OC] [Cited by in Crossref: 166] [Cited by in F6Publishing: 77] [Article Influence: 11.9] [Reference Citation Analysis]
629 Liu S, Alexander RK, Lee CH. Lipid metabolites as metabolic messengers in inter-organ communication. Trends Endocrinol Metab 2014;25:356-63. [PMID: 24895003 DOI: 10.1016/j.tem.2014.05.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
630 Kasuga K, Suga T, Mano N. Bioanalytical insights into mediator lipidomics. J Pharm Biomed Anal 2015;113:151-62. [PMID: 25769667 DOI: 10.1016/j.jpba.2015.02.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
631 Das UN. A defect in the activities of Δ6 and Δ5 desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease. World J Diabetes 2011; 2(11): 176-188 [PMID: 22087354 DOI: 10.4239/wjd.v2.i11.176] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
632 Schmid T, Brüne B. Prostanoids and Resolution of Inflammation - Beyond the Lipid-Mediator Class Switch. Front Immunol 2021;12:714042. [PMID: 34322137 DOI: 10.3389/fimmu.2021.714042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Zhang T, Hao H, Zhou X. The role of lipoxin in regulating tumor immune microenvironments. Prostaglandins & Other Lipid Mediators 2019;144:106341. [DOI: 10.1016/j.prostaglandins.2019.106341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
634 Kim C, Wilcox-Adelman S, Sano Y, Tang WJ, Collier RJ, Park JM. Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus. Proc Natl Acad Sci U S A 2008;105:6150-5. [PMID: 18427110 DOI: 10.1073/pnas.0800105105] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
635 Brown CR, Dennis EA. Borrelia burgdorferi infection induces lipid mediator production during Lyme arthritis. Biochimie 2017;141:86-90. [PMID: 28630010 DOI: 10.1016/j.biochi.2017.06.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
636 Blaho VA, Zhang Y, Hughes-Hanks JM, Brown CR. 5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis. J Immunol 2011;186:3076-84. [PMID: 21270404 DOI: 10.4049/jimmunol.1003473] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
637 Kowal-Bielecka O, Kowal K, Distler O, Gay S. Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease--insights and potential therapeutic implications. Nat Clin Pract Rheumatol 2007;3:43-51. [PMID: 17203008 DOI: 10.1038/ncprheum0375] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
638 Mirakaj V, Dalli J, Granja T, Rosenberger P, Serhan CN. Vagus nerve controls resolution and pro-resolving mediators of inflammation. J Exp Med 2014;211:1037-48. [PMID: 24863066 DOI: 10.1084/jem.20132103] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 13.5] [Reference Citation Analysis]
639 Thoo L, Noti M, Krebs P. Keep calm: the intestinal barrier at the interface of peace and war. Cell Death Dis 2019;10:849. [PMID: 31699962 DOI: 10.1038/s41419-019-2086-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
640 Beck-speier I, Dayal N, Karg E, Maier KL, Schumann G, Schulz H, Semmler M, Takenaka S, Stettmaier K, Bors W, Ghio A, Samet JM, Heyder J. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radical Biology and Medicine 2005;38:1080-92. [DOI: 10.1016/j.freeradbiomed.2005.01.004] [Cited by in Crossref: 114] [Cited by in F6Publishing: 105] [Article Influence: 6.7] [Reference Citation Analysis]
641 Wéra O, Lancellotti P, Oury C. The Dual Role of Neutrophils in Inflammatory Bowel Diseases. J Clin Med 2016;5:E118. [PMID: 27999328 DOI: 10.3390/jcm5120118] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 16.8] [Reference Citation Analysis]
642 Luo C, Urgard E, Vooder T, Metspalu A. The role of COX-2 and Nrf2/ARE in anti-inflammation and antioxidative stress: Aging and anti-aging. Medical Hypotheses 2011;77:174-8. [DOI: 10.1016/j.mehy.2011.04.002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 6.6] [Reference Citation Analysis]
643 Jordan PM, Gerstmeier J, Pace S, Bilancia R, Rao Z, Börner F, Miek L, Gutiérrez-Gutiérrez Ó, Arakandy V, Rossi A, Ialenti A, González-Estévez C, Löffler B, Tuchscherr L, Serhan CN, Werz O. Staphylococcus aureus-Derived α-Hemolysin Evokes Generation of Specialized Pro-resolving Mediators Promoting Inflammation Resolution. Cell Rep 2020;33:108247. [PMID: 33053344 DOI: 10.1016/j.celrep.2020.108247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
644 Poulcharidis D, Belfor K, Kros A, van Kasteren SI. A flow cytometry assay to quantify intercellular exchange of membrane components. Chem Sci 2017;8:5585-90. [PMID: 28970937 DOI: 10.1039/c7sc00260b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
645 Wang H, Daggy BP. The Role of Fish Oil in Inflammatory Eye Diseases. Biomed Hub 2017;2:1-12. [PMID: 31988905 DOI: 10.1159/000455818] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
646 Norris PC, Gosselin D, Reichart D, Glass CK, Dennis EA. Phospholipase A2 regulates eicosanoid class switching during inflammasome activation. Proc Natl Acad Sci USA. 2014;111:12746-12751. [PMID: 25139986 DOI: 10.1073/pnas.1404372111] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 10.0] [Reference Citation Analysis]
647 Yamaguchi J, Kinoshita K, Ihara S, Furukawa M, Sakurai A. The Clinical Significance of Low Serum Arachidonic Acid in Sepsis Patients with Hypoalbuminemia. Intern Med 2018;57:1833-40. [PMID: 29491308 DOI: 10.2169/internalmedicine.9124-17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
648 Pritchard KA Jr, Weihrauch D. A novel path of improving heart function after infarction. J Mol Cell Cardiol 2015;84:200-1. [PMID: 25944086 DOI: 10.1016/j.yjmcc.2015.04.024] [Reference Citation Analysis]
649 Tegeder I, Geisslinger G. Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences? Naunyn Schmied Arch Pharmacol 2006;373:1-17. [DOI: 10.1007/s00210-006-0044-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
650 Birukov KG, Karki P. Injured lung endothelium: mechanisms of self-repair and agonist-assisted recovery (2017 Grover Conference Series). Pulm Circ 2018;8:2045893217752660. [PMID: 29261029 DOI: 10.1177/2045893217752660] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
651 Mustafa M, Zarrough A, Bolstad AI, Lygre H, Mustafa K, Hasturk H, Serhan C, Kantarci A, Van Dyke TE. Resolvin D1 protects periodontal ligament. Am J Physiol Cell Physiol 2013;305:C673-9. [PMID: 23864609 DOI: 10.1152/ajpcell.00242.2012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
652 Fiala M, Kooij G, Wagner K, Hammock B, Pellegrini M. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. FASEB J 2017;31:3229-39. [PMID: 28420693 DOI: 10.1096/fj.201700065R] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
653 Joffre C, Rey C, Layé S. N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation. Front Pharmacol 2019;10:1022. [PMID: 31607902 DOI: 10.3389/fphar.2019.01022] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
654 Meital LT, Windsor MT, Maynard AE, Schulze K, Magee R, O'Donnell J, Jha P, Meital CY, Perissiou M, Coverdale S, Golledge J, Kuballa AV, Bailey TG, Askew CD, Russell FD. Endotoxin Tolerance in Abdominal Aortic Aneurysm Macrophages, In Vitro: A Case-Control Study. Antioxidants (Basel) 2020;9:E896. [PMID: 32967278 DOI: 10.3390/antiox9090896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
655 Orr SK, Butler KL, Hayden D, Tompkins RG, Serhan CN, Irimia D. Gene Expression of Proresolving Lipid Mediator Pathways Is Associated With Clinical Outcomes in Trauma Patients. Crit Care Med 2015;43:2642-50. [PMID: 26488221 DOI: 10.1097/CCM.0000000000001312] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
656 Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 2018;128:2657-69. [PMID: 29757195 DOI: 10.1172/JCI97943] [Cited by in Crossref: 410] [Cited by in F6Publishing: 250] [Article Influence: 102.5] [Reference Citation Analysis]
657 Wang X, Puerta E, Cedazo-Minguez A, Hjorth E, Schultzberg M. Insufficient resolution response in the hippocampus of a senescence-accelerated mouse model--SAMP8. J Mol Neurosci 2015;55:396-405. [PMID: 24913689 DOI: 10.1007/s12031-014-0346-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
658 Yakah W, Ramiro-Cortijo D, Singh P, Brown J, Stoll B, Kulkarni M, Oosterloo BC, Burrin D, Maddipati KR, Fichorova RN, Freedman SD, Martin CR. Parenteral Fish-Oil Containing Lipid Emulsions Limit Initial Lipopolysaccharide-Induced Host Immune Responses in Preterm Pigs. Nutrients 2021;13:205. [PMID: 33445698 DOI: 10.3390/nu13010205] [Reference Citation Analysis]
659 Lim JY, Park CK, Hwang SW. Biological Roles of Resolvins and Related Substances in the Resolution of Pain. Biomed Res Int 2015;2015:830930. [PMID: 26339646 DOI: 10.1155/2015/830930] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
660 Komarnytsky S, Rathinasabapathy T, Wagner C, Metzger B, Carlisle C, Panda C, Le Brun-Blashka S, Troup JP, Varadharaj S. Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils. Int J Mol Sci 2021;22:5479. [PMID: 34067450 DOI: 10.3390/ijms22115479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
661 Welty FK, Schulte F, Alfaddagh A, Elajami TK, Bistrian BR, Hardt M. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B4. FASEB J 2021;35:e21448. [PMID: 33749913 DOI: 10.1096/fj.202002471R] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
662 Ross EA, Devitt A, Johnson JR. Macrophages: The Good, the Bad, and the Gluttony. Front Immunol 2021;12:708186. [PMID: 34456917 DOI: 10.3389/fimmu.2021.708186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
663 Andina N, Conus S, Schneider EM, Fey MF, Simon HU. Induction of Bim limits cytokine-mediated prolonged survival of neutrophils. Cell Death Differ 2009;16:1248-55. [DOI: 10.1038/cdd.2009.50] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
664 Hedger MP. The Immunophysiology of Male Reproduction. Knobil and Neill's Physiology of Reproduction. Elsevier; 2015. pp. 805-92. [DOI: 10.1016/b978-0-12-397175-3.00019-3] [Cited by in Crossref: 11] [Article Influence: 1.6] [Reference Citation Analysis]
665 David S, López-Vales R. Bioactive Lipid Mediators in the Initiation and Resolution of Inflammation after Spinal Cord Injury. Neuroscience 2021;466:273-97. [PMID: 33951502 DOI: 10.1016/j.neuroscience.2021.04.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
666 Schlegel M, Körner A, Kaussen T, Knausberg U, Gerber C, Hansmann G, Jónasdóttir HS, Giera M, Mirakaj V. Inhibition of neogenin fosters resolution of inflammation and tissue regeneration. J Clin Invest 2018;128:4711-26. [PMID: 30222138 DOI: 10.1172/JCI96259] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
667 Chan MM, Moore AR. Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J Immunol. 2010;184:6418-6426. [PMID: 20435922 DOI: 10.4049/jimmunol.0903816] [Cited by in Crossref: 122] [Cited by in F6Publishing: 121] [Article Influence: 10.2] [Reference Citation Analysis]
668 Lopes-Ferreira M, Gomes EM, Bruni FM, Ferreira MJ, Charvet P, Lima C. First report of interruption of mast cell degranulation and endothelial cells activation by anti-inflammatory drugs controlling the acute response provoked by Pseudoplatystoma fasciatum fish venom. Toxicon 2014;90:237-48. [PMID: 25152168 DOI: 10.1016/j.toxicon.2014.08.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
669 Mani AM, Chattopadhyay R, Singh NK, Rao GN. Cholesterol crystals increase vascular permeability by inactivating SHP2 and disrupting adherens junctions. Free Radic Biol Med 2018;123:72-84. [PMID: 29782988 DOI: 10.1016/j.freeradbiomed.2018.05.068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
670 Panigrahy D, Gilligan MM, Serhan CN, Kashfi K. Resolution of inflammation: An organizing principle in biology and medicine. Pharmacol Ther 2021;:107879. [PMID: 33915177 DOI: 10.1016/j.pharmthera.2021.107879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
671 Pirault J, Bäck M. Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease. Front Pharmacol 2018;9:1273. [PMID: 30487747 DOI: 10.3389/fphar.2018.01273] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 12.8] [Reference Citation Analysis]
672 Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16:531-543. [PMID: 31312042 DOI: 10.1038/s41575-019-0172-4] [Cited by in Crossref: 142] [Cited by in F6Publishing: 141] [Article Influence: 47.3] [Reference Citation Analysis]
673 Filep JG. Lipid mediator interplay: resolvin D1 attenuates inflammation evoked by glutathione-conjugated lipid peroxidation products. Br J Pharmacol 2009;158:1059-61. [PMID: 19845687 DOI: 10.1111/j.1476-5381.2009.00235.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
674 Motwani MP, Gilroy DW. Macrophage development and polarization in chronic inflammation. Semin Immunol 2015;27:257-66. [PMID: 26216597 DOI: 10.1016/j.smim.2015.07.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 8.6] [Reference Citation Analysis]
675 Viola JR, Lemnitzer P, Jansen Y, Csaba G, Winter C, Neideck C, Silvestre-Roig C, Dittmar G, Döring Y, Drechsler M, Weber C, Zimmer R, Cenac N, Soehnlein O. Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice. Circ Res 2016;119:1030-8. [PMID: 27531933 DOI: 10.1161/CIRCRESAHA.116.309492] [Cited by in Crossref: 106] [Cited by in F6Publishing: 77] [Article Influence: 17.7] [Reference Citation Analysis]
676 Espinosa G, Plaza A, Schenffeldt A, Alarcón P, Gajardo G, Uberti B, Morán G, Henríquez C. Equine bone marrow-derived mesenchymal stromal cells inhibit reactive oxygen species production by neutrophils. Vet Immunol Immunopathol 2020;221:109975. [PMID: 32087476 DOI: 10.1016/j.vetimm.2019.109975] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
677 Rinaldi SF, Hutchinson JL, Rossi AG, Norman JE. Anti-inflammatory mediators as physiological and pharmacological regulators of parturition. Expert Review of Clinical Immunology 2014;7:675-96. [DOI: 10.1586/eci.11.58] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
678 Hurley BP, Pirzai W, Mumy KL, Gronert K, McCormick BA. Selective eicosanoid-generating capacity of cytoplasmic phospholipase A2 in Pseudomonas aeruginosa-infected epithelial cells. Am J Physiol Lung Cell Mol Physiol 2011;300:L286-94. [PMID: 21097525 DOI: 10.1152/ajplung.00147.2010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
679 Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of Inflammation: What Controls Its Onset? Front Immunol 2016;7:160. [PMID: 27199985 DOI: 10.3389/fimmu.2016.00160] [Cited by in Crossref: 214] [Cited by in F6Publishing: 213] [Article Influence: 35.7] [Reference Citation Analysis]
680 Dias IHK, Milic I, Heiss C, Ademowo OS, Polidori MC, Devitt A, Griffiths HR. Inflammation, Lipid (Per)oxidation, and Redox Regulation. Antioxid Redox Signal 2020;33:166-90. [PMID: 31989835 DOI: 10.1089/ars.2020.8022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
681 Gilroy D, Lawrence T. The resolution of acute inflammation: A ‘tipping point’ in the development of chronic inflammatory diseases. In: Rossi AG, Sawatzky DA, editors. The Resolution of Inflammation. Basel: Birkhäuser; 2008. pp. 1-18. [DOI: 10.1007/978-3-7643-7506-5_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
682 Serhan CN, Lu Y, Hong S, Yang R. Mediator Lipidomics: Search Algorithms for Eicosanoids, Resolvins, and Protectins. Lipidomics and Bioactive Lipids: Mass‐Spectrometry–Based Lipid Analysis. Elsevier; 2007. pp. 275-317. [DOI: 10.1016/s0076-6879(07)32012-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
683 Goh J, Godson C, Brady HR, Macmathuna P. Lipoxins: Pro-resolution lipid mediators in intestinal inflammation. Gastroenterology 2003;124:1043-54. [DOI: 10.1053/gast.2003.50154] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
684 Nogueira-neto FDS, Amorim RL, Brigatte P, Picolo G, Ferreira WA, Gutierrez VP, Conceição IM, Della-casa MS, Takahira RK, Nicoletti JLM, Cury Y. The analgesic effect of crotoxin on neuropathic pain is mediated by central muscarinic receptors and 5-lipoxygenase-derived mediators. Pharmacology Biochemistry and Behavior 2008;91:252-60. [DOI: 10.1016/j.pbb.2008.08.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
685 Hellmann J, Zhang MJ, Tang Y, Rane M, Bhatnagar A, Spite M. Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production. J Immunol 2013;191:1383-92. [PMID: 23785121 DOI: 10.4049/jimmunol.1203369] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 6.8] [Reference Citation Analysis]
686 Eftedal I, Flatberg A, Drvis I, Dujic Z. Immune and inflammatory responses to freediving calculated from leukocyte gene expression profiles. Physiol Genomics 2016;48:795-802. [PMID: 27614202 DOI: 10.1152/physiolgenomics.00048.2016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
687 Sehanobish E, Asad M, Barbi M, Porcelli SA, Jerschow E. Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease. Front Immunol 2021;12:695815. [PMID: 34305932 DOI: 10.3389/fimmu.2021.695815] [Reference Citation Analysis]
688 Thatcher TH, Woeller CF, McCarthy CE, Sime PJ. Quenching the fires: Pro-resolving mediators, air pollution, and smoking. Pharmacol Ther 2019;197:212-24. [PMID: 30759375 DOI: 10.1016/j.pharmthera.2019.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
689 Loynes CA, Lee JA, Robertson AL, Steel MJ, Ellett F, Feng Y, Levy BD, Whyte MKB, Renshaw SA. PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo. Sci Adv 2018;4:eaar8320. [PMID: 30191175 DOI: 10.1126/sciadv.aar8320] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 21.8] [Reference Citation Analysis]
690 Wang X, Zhu M, Hjorth E, Cortés-Toro V, Eyjolfsdottir H, Graff C, Nennesmo I, Palmblad J, Eriksdotter M, Sambamurti K, Fitzgerald JM, Serhan CN, Granholm AC, Schultzberg M. Resolution of inflammation is altered in Alzheimer's disease. Alzheimers Dement 2015;11:40-50.e1-2. [PMID: 24530025 DOI: 10.1016/j.jalz.2013.12.024] [Cited by in Crossref: 144] [Cited by in F6Publishing: 141] [Article Influence: 18.0] [Reference Citation Analysis]
691 Gavins FNE, Yona S, Kamal AM, Flower RJ, Perretti M. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 2003;101:4140-7. [DOI: 10.1182/blood-2002-11-3411] [Cited by in Crossref: 143] [Cited by in F6Publishing: 149] [Article Influence: 7.5] [Reference Citation Analysis]
692 Seeger DR, Golovko SA, Golovko MY. Blood-Brain Barrier Is the Major Site for a Rapid and Dramatic Prostanoid Increase upon Brain Global Ischemia. Lipids 2020;55:79-85. [PMID: 31814137 DOI: 10.1002/lipd.12205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [